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Huntington’s disease
Huntington’s disease (HD) is an inherited rare autosomal dominant disorder, caused by a 
mutation in the HTT-gen, causing progressive neural degeneration of the basal ganglia and 
gradual atrophy of frontal and temporal cortex [1]. The disease is characterized by movement 
disturbances, neuropsychiatric disturbances and cognitive deterioration leading to a complete 
dependency for daily life activities [2]. Clinically, a great variation in age at onset, duration of 
illness, and course of the disease is seen. The mean age of onset is between the age of 30 
and 50 years, and once manifest, the patient’s life expectancy is about 15-20 years [3]. Three 
clinical stages can be described: Stage I, in which patients develop initial symptoms but are still 
independent. Stage II, patients become more dependent as the disease progresses. Stage III is 
the end-of-life stage: patients become completely dependent for all daily life activities [2,3]. 
The prevalence of HD in Europe, North America and Australia is about 10 per 100.000 [4]. In 
the Netherlands there are approximately 1,700 persons with HD.
Communication problems in HD
The characteristics mentioned above often result in loss of expressive and communicative 
skills, especially in the advanced stage of the disease. Verbal communication is often affected, 
due to motor impairment of speech. In addition, as a result of the cognitive decline, word 
retrieval is often impaired, although the knowledge of vocabulary is retained. As the disease 
progresses, the language content can no longer be processed properly and adequate com-
munication becomes challenging [1].
The gradual deterioration of the communication skills contributes to a sometimes rapidly 
increasing inability to participate in different life situations [5]. The communication problems 
may have a great impact on the quality of life of the patients and formal and informal carers.
Behavioral problems in HD
Behavioral problems are common among patients with HD. They are an important feature of 
HD and contribute to impairment of quality of life [6]. The most common symptoms are loss 
of energy and initiative, poor perseverance and quality of work, impaired judgment, poor 
self-care and emotional blunting. Affective symptoms such as depression, anxiety, apathy and 
irritability also occur frequently [7].
While there is no cure for HD, the emphasis is on the care of patients with HD, especially those 
in the advanced stage of the disease [2]. The aim of all treatment is on improving the quality 
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In conclusion, precise aims and methods in relation to the stage of the disease, as well as the 
effectiveness of music therapy, are not well determined (see table “Music Therapy and HD: 
Referrals and Goals” in chapter 2). There is a need for a systematic study to determine the 
indications to use music therapy and to study the effectiveness of music therapy in HD [14]. 
Despite positive findings in the field, studies linking music therapy and HD together are lim-
ited. Therefore, review of the broader field of neurodegenerative diseases that have similar 
symptoms to HD is essential to develop the theory building about MT and HD further.
Over the past decades, music therapy (MT) has been developed for patients with other neu-
rodegenerative diseases, such as dementia [15,16]. There is evidence that music therapy 
influences emotional well-being positively and that participation in music therapy increases 
social response in persons with dementia, thus providing additional means of communication 
and enabling the patient to express his or her needs and emotions [17,18]. Through music, 
contact can be established, especially as language functions deteriorates during the later 
stages of the dementia process [19]. Furthermore, enhancing the ability for self-expression, 
contributing to improvement of the quality of life, has been reported by Lee and McFerran 
who describe five females in a multiple case study with profound and multiple disabilities using 
patient preferred song-choices in music therapy [20]. The patient can be stimulated to recall 
life experiences through music. In the music therapy session this can be used as a catharsis 
to experience emotions. In a recently update Cochrane review on music-based therapeutic 
interventions for people with dementia [21] the authors conclude that music therapy may 
reduce depressive symptoms. 
Based on the above-mentioned benefits, the assumption can be made that MT is beneficial to 
patients with HD on communicative and expressive skills. Improvement of these skills might 
lead to improvement of behavior, eventually leading to improvement of the quality of life of 
patients with Huntington’s disease [14]. 
Aims and outline of this thesis
The specific aim of this thesis was to explore the effectiveness of music therapy in patients with 
HD. To achieve this goal, the first step was to study the available literature on music therapy 
in HD. The result of this literature search is described in chapter 2. 
of life of patients with HD. Music therapy could be a complimentary, non-pharmacological 
intervention to reach this goal. 
Music therapy
Among the many definitions of music therapy, the most used one is the one from the American 
Music Therapy Association (AMTA) which describes music therapy as follows: 
“ Music therapy is the clinical and evidence-based use of music interventions to accom-
plish individualized goals within a therapeutic relationship by a credentialed professional 
who has completed an approved music therapy program” [8].
Music therapists assess emotional well-being, physical health, social functioning, communica-
tion abilities, and cognitive skills through musical responses. Music therapists design sessions 
for individuals and groups based on client needs using music improvisation, receptive music 
listening, song writing, lyric discussion, music and imagery, music performance, and learning 
through music. Finally, they are part of the multidisciplinary team and thus participate in 
interdisciplinary treatment planning, ongoing evaluation, and follow-up [8]. 
Music Therapy and Huntington’s Disease 
As the ability to communicate and express oneself deteriorates over time, music therapy 
could play an important role in the treatment of patients with HD in all stages of the disease. 
Through music therapy an additional means of communication can be provided, enabling 
the patient to express his or her needs and emotions, and to recall life experiences which in 
patients with HD is also affected. 
Specific literature about MT in HD is scarce. Research into the effect that music therapy has 
on HD began to develop in the late 1970’s and early 1980’s. Studies include: speech facilita-
tion through singing [9], music and movement programs [10], emotional expression by use 
of song-writing [11], participation and communication [12]. The results of a music therapy 
referral audit by Daveson (2007) revealed that patients with HD were most likely to be referred 
to a music therapist due to a need for emotional expression, and the maintenance of commu-
nication skills and social relationships. [13]. In a comprehensive systematic literature review 
(see chapter 2 of this thesis), Bruggen-Rufi Van and Roos [14] conclude that music therapy 
interventions vary throughout the different stages of the disease and are not yet applied 
optimally. Not the stage of the disease, but the individual treatment goals (see table below) 
seem to be more determinative for the music therapy indications. 
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Subsequently, we conducted a focus group study to investigate whether six professionals from 
different disciplines, who all have a considerable amount of years of clinical experience with 
patients with HD, recognized a possible beneficial role for the music therapist in relation to 
improvement of the quality of life for people with HD. The outcome of this study is described 
in chapter 3. 
Both the literature and the focus group study helped us to design a randomized controlled trial 
to study the effect of music therapy in HD. The protocol of this RCT is described in chapter 4. 
The study and the results of the RCT are described in chapter 5.
Performing a multi-center RCT studying the efficacy of music therapy with vulnerable patients 
in four different long-term care facilities is considered to be a complex intervention. In order 
to elucidate the results and to investigate how the study was performed, we conducted a 
process-evaluation. This process-evaluation, described in chapter 6, highlighted the many 
barriers and facilitators to perform such a complex intervention, and the outcome helped us 
to elucidate the results of this quantitative effectiveness study, resulting in recommendations 
for future studies in regard to design and measurement tools. 
In chapter 7, two case reports with two patients who benefit from music therapy are described 
for illustration. At the same time, these case examples give the reader some insight in the 
real-world context in which music therapy is practiced. 
Finally, the main conclusions of this thesis are summarized and discussed in chapter 8. In this 
chapter we will build on the definitions of music therapy to determine whether the methods 
that we used throughout this thesis were in compliance with these descriptions, followed by 
future perspectives and closing remarks.
“One good thing about music, when it hits you,
you feel no pain”
Bob Marley (1945 – 1981.) Uit: “Trenchtown rock”
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Abstract
Huntington’s disease is a progressive, neurodegenerative, autosomal dominant disease char-
acterized by motor- and psychiatric disturbances, and cognitive decline. Since there is no cure, 
all treatment is aimed at improving quality of life (QoL). One form of non-drug therapy which 
is barely recognized, is music therapy. The literature on its use and effect in patients with 
Huntington’s disease is limited. We therefore performed a detailed literature survey in order 
to delineate the different types of music therapy interventions and their aims. Music therapy 
studies were included when targeting: (1) motor disturbances; (2) cognitive disturbances; (3) 
psychiatric disturbances; and (4) emotional/social disturbances. A total of eight studies that 
met these criteria were analyzed. We found that music therapy interventions vary throughout 
the different stages of the disease and are not yet applied optimally. Not the stage of the dis-
ease but the individual treatment goals seem to be more determinative for the music therapy 
indications. In conclusion, precise aims and methods in relation to the stage of the disease are 
not well determined. There is a need for systematic study of this treatment option.
Introduction
Huntington’s disease (HD) is a rare neurodegenerative disorder of the central nervous system. 
It is a progressive, autosomal dominant disease, characterized by a triad of symptoms and 
signs, consisting of: (1) motor disturbances: chorea and hypokinesia; (2) cognitive decline; and 
(3) psychiatric disturbances: depression and behavioral changes (Roos, 2010). The prevalence 
of HD ranges from 1 : 143 in Venezuela to 1 : 10.000.000 in the black population of South 
Africa. In the Caucasian population the prevalence is estimated to be between 5 and 10 per 
100,000 (Al-Jader, Harper, Krawczak, & Palmer, 2001).
The disease can be roughly divided into three stages: the early, the middle, and the late stage. 
As the disease progresses, the dependability of the patient increases. Admission to a long term 
care facility (LTCF) is unavoidable in most cases.
To date, there is no drug to cure or delay the onset of the disease. The majority of drugs is 
prescribed to treat the motor and psychiatric signs. Besides medication, many other non-drug 
interventions are available such as physiotherapy, occupational therapy, speech therapy, dieti-
cian advice, psychological support, social worker help, and music therapy. All treatment must 
be individually tailored, as the symptoms and signs are different for each person and change 
over time. The intention of all forms of treatment is to improve quality of life (Roos, 2010).
The term quality of life reflects the overall status of a combination of factors: a person’s health, 
symptoms, and level of physical and social functioning. Functional and cognitive impairment 
are significantly correlated with the patient’ s QoL (EHDN website1; Ready, Mathews, Leserman 
& Paulsen, 2008). Health-related quality of life (HrQoL) is defined as follows: “The optimum 
levels of physical role and social functioning, including relationships and perceptions of health, 
fitness, life satisfaction and well-being” (Bowling, 1995). 
Ho, Gilbert, Mason, Goodman, and Barker (2009) conclude that depressive mood and func-
tional ability are critically linked to health-related QoL in HD. In a previous study, Helder, 
Kaptein, Kempen van, Houwelingen van, and Roos (2001) conclude that physical and psycho-
social symptoms have a great impact on the patient’s well-being. 
1 European Huntington’s Disease Network (EHDN), working group Quality of Life. Retrieved from  
http://www.euro-hd.net/html/network/groups/qual. Last accessed December 23rd, 2013.
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History of Music Therapy
The first use of music in relation to illness can be traced back to ancient Egypt. More systematic 
studies on the effects of music on physiological processes such as cardiac output, respiration, 
pulse rate, and blood pressure were first carried out at end of the 19th century. Nowadays 
music is provided for relaxation purposes and pain relief (Bradt & Dileo, 2009).
The 20th century discipline began after the First World War when musicians went to Veteran 
hospitals around the country to play for the thousands of veterans suffering from physical and 
emotional traumas. It was soon evident that the hospital musicians required some prior trai-
ning before entering the facility and so the first music therapy degree programme was initiated 
in 1943 in the United States. In 1998, the American Music Therapy Association (AMTA) united 
the National Association for Music Therapy (founded in 1950) and the American Association 
for Music Therapy (founded in 1971) (AMTA website).
During the last decades, new MRI techniques have made it possible to visualize the brain while 
playing or listening to music (Peretz & Zatorre, 2009). Studies have revealed that each musical 
parameter (e.g., rhythm, melody, harmony, pitch) seems to engage a broad network of brain 
regions (Patel, 2008). Processing the musical structure appears to trigger networks in the 
prefrontal and the interior frontal cortex, superior temporal poles and the cerebellum. When 
the music is emotionally meaningful to the listener, activity extends to the ventral tegmental 
area, the accumbens nucleus and the hypothalamus (Levitin, 2009). 
It has been revealed that music and motor control share specific neural circuits. This has led 
to the assumption that music could improve movement problems in patients with Parkinson’s 
disease and Huntington’s disease (Thaut & McIntosh, 2010). Also, music has been shown to 
activate distinct neural pathways in the brain associated with emotion, such as the insula 
and cingulate cortex, hypothalamus, hippocampus, amygdala, and prefrontal cortex (Juslin & 
Sloboda, 2010). It has, therefore, been suggested that many more patients with dementia 
and other age-related conditions, developmental and learning disabilities, substance abuse 
problems, brain injuries, physical disabilities, and acute and chronic pain, could benefit from 
this treatment (Magee & Davidson, 2008; Schmid & Aldridge, 2004; Thaut, 2005). 
There is evidence that rhythmic auditory stimulation improves gait in patients with Parkinson’s 
Disease (PD) (Thaut et al., 1996). Pacchetti et al. (2000) showed in a randomized controlled, 
single-blinded study beneficial effects of music therapy on affective and behavioral functions 
in PD patients. 
In 2011, the European Huntington’s Disease Network (EHDN) Quality of Life Working Group 
initiated a qualitative research study on the impact of HD across the entire disease spectrum 
(Ho & Hocaoglu, 2011). The outcome provides important implications for the management and 
development of interventions throughout all stages. The physical/functional theme peaked 
throughout the different stages, indicating that these issues were raised more frequently over 
the course of the disease. There were no significant changes between stages for the emotional 
and social themes. The cognitive impairments only featured in the early and middle stages. 
In the advanced late stage, the cognitive theme hardly featured any more, probably due to 
the degree of cognitive impairment which affects insight at this stage (Ho & Hocaoglu, 2011). 
Also, in the late stages, the physical impairments become more and more evident which makes 
determination of the cognitive, emotional and social themes extremely difficult. 
In the attempt to meet the needs of the individual, the challenge is to find adequate responses 
and to develop relevant and effective therapeutic strategies (Gilbertson, 2005; Aldridge, 2005). 
One form of non-drug therapy which is barely recognized, is music therapy. Music therapy 
recognizes individual needs and can be adapted to meet them. Over the past decades, music 
therapy is developed for patients with neurodegenerative diseases, recognizing the individual 
needs of the patients (Cohen-Mansfield, 2000).
What is Music Therapy? 
The American Music Therapy Association (AMTA)2 defines music therapy as follows: 
“Music therapy is the clinical and evidence-based use of music interventions to accomplish 
individualized goals within a therapeutic relationship by a credentialed professional who 
has completed an approved music therapy program”.
Music therapists assess emotional well-being, physical health, social functioning, communi-
cation abilities, and cognitive skills through musical responses. Music therapists design music 
sessions for individuals and groups based on client needs using music improvisation, receptive 
music listening, song writing, lyric discussion, music and imagery, music performance, and 
learning through music. Finally, they are part of the multidisciplinary team and thus participate 
in interdisciplinary treatment planning, ongoing evaluation, and follow-up (AMTA website).
2  American Music Therapy Association [homepage on the Internet. Retrieved from:  
http://www.musictherapy.org. Last accessed December 23rd, 2013].





















































Figure 1. Flow chart search string (last search May 13th, 2014).
Results
The literature contains many case reports suggesting that music therapy may have an effect 
on the function of people with neurodegenerative diseases. The majority of these articles 
describe the development of music therapy practice, illustrated by single case studies, clinical 
reports, and descriptions of methodology. The reported benefits of music therapy for neuro-
degenerative diseases in general are summarized in Table 1 (Aldridge, 2005). 
Based on the insights mentioned above one can assume that music therapy could be a suitable 
non-drug intervention for HD. We, therefore, reviewed the literature to find out the different 
techniques, the primary outcome measures, and assessments used in music therapy in HD.
Methodology
A systematic literature search was conducted for any related publication, published between 
1950 and 2014, in the following databases: Medline/PubMed; Embase, Cinahl, PsychINFO/
PsycIndex, and Web of Science. The following terms were included: music, music therapy, in 
combination with the terms Huntington and Huntington’s disease.
Furthermore, (hand)searches were carried out in specific music(therapy) databases, such as:
- CAIRSS (Computer-Assisted Information Retrieval Service System), a bibliographic data-
base of music research literature, including national and international Music Therapy 
journals;
- The Center for Biomedical Research in Music (CBRM);
- The digital database of the Music Therapy Neurology Network (MTNN);
- The Nordoff Robins Music Therapy Research Program.
Also, specific music therapy journals were (hand)searched including the Journal of Music 
Therapy and Music Therapy Perspectives, as well as reviewing reference lists of the relevant 
publications. Finally, conference proceedings and dissertation abstracts were reviewed.
The following inclusion criteria were used:
- Participants had to be formally diagnosed as having Huntington’s disease;
- Music therapy had to be involved, targeting any of the following symptoms and signs that 
play a role in the quality of life of patients suffering from HD: (1) motor disturbances; 
(2) cognitive disturbances; (3) psychiatric disturbances; and (4) emotional/social distur-
bances.
The references used in this article were purposefully limited to publications that focused 
specifically on music therapy. All music therapy references in relation to Huntington’s disease 
were retrieved and reviewed (see Figure 1).
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and (3) sing along. She found that small music therapy groups helped maintain and improve 
functioning in the following areas: participation, communication (both verbal and nonver-
bal), concentration, memory, relaxation, movement, self-esteem, self-expression, and social 
interaction.
Magee (1995a, 1995b) focused on different stages of HD and how different music therapy 
interventions could be shaped to meet the changing needs throughout disease progression. 
She states that in the early stage the need for active participation in music therapy is desir-
able, preferably individual sessions. In the mid-stage group, participation is recommended, 
firstly because participating in a group gives the patient more time to react (and thus less 
confrontation with his decline), secondly because the other patients in the group can be used 
as a model for other group members. Finally, in the late stage the use of receptive methods 
is recommended in group-settings. Active playing of an instrument for as long as possible is 
encouraged.
Brandt (2000) investigated the effect of performing a favorite song on the involuntary move-
ments of six HD patients in the mid- and late stage. She concluded that there was no significant 
difference in effect between singing the favorite song and reduction of involuntary movements. 
Davis and Magee (2001) explored the use of a particular music therapy intervention. They 
describe a study about the use of structure within musical (active) improvisations with an 
HD-client. The main goal was to improve the expressive responses and to support interaction 
by increasing communicative contact through musical parameters. 
Quantitative Studies
Grocke-Erdonmez (1976) conducted the first study into HD and music therapy in 7 HD patients. 
She focused on the stimulation of expressive speech through melodic speech therapy. She did 
find that several patients were able to sing out words that they had previously had trouble 
articulation through speech.
Thaut, Miltner, Lange, Hurt, and Hoemberg (1999) investigated the rhythmic synchronization 
ability of 27 HD patients under different conditions and circumstances using the Rhythmic 
Auditory Stimulation (RAS) techniques. The gait speed of most of the patients could be changed 
in the direction of the RAS cue. Synchronization of the steps was more difficult for patients in 
the early stage of the disease. Thaut et al. (1999) concludes that the ability to process auditive 
stimuli decreases as the disease progresses, due to deterioration of the cognitive abilities.
Table 1 Benefits of Music Therapy for the Neurodegenerative Diseases
Meets the needs of individual patients and their characteristics
Promotes dialogue and the maintenance of an identity that has a broad repertoire of possibilities
Reintegrates the person within a communicative ecology and prevents isolation
Offers a flexible temporal structure for processing temporal information where timing can be temporarily 
recovered and practiced
Utilizes gestural abilities, including utterance, binding events together that are indicative of ability
Gestures seen as attempts to regain cognition, not seen as failed abilities
Encourages rhythmical movement
Regulates emotional arousal in terms of expression and inhibition with implications for sufferers and caregivers
Needs can be expressed
Motivates communication and participation without being speech dependent
Attention, arousal, affect and action embodied in musical form
Note. Source: Aldridge, 2005.
When searching for the (MeSH)terms “Huntington’s Disease, Music and Music Therapy” we 
found a total of 85 references. After omitting the duplicates and the articles not fulfilling the 
inclusion criteria, nine articles remained: five practice based studies, two quantitative studies 
and two qualitative studies. 
The practice based and quantitative studies were screened on research design (see Table 2).
The music therapy goals and interventions described in the reviewed articles were categorized 
according to the targeted symptoms and signs that play a part in the quality of life op patients 
suffering from HD, i.e., physical (motor) (n = 5), cognitive (n = 3), psychiatric goals (n = 1), and 
social/emotional goals (n = 5) (see Table 3). 
Practice Based Studies
Hoskyns (1982) focused on the effects of music therapy on counteracting anxiety and frustra-
tion by encouraging relaxation and group participation, and on reducing choreic movement 
by use of singing, playing, and listening. The most significant findings were that group singing 
seemed to be very beneficial and that playing musical instruments increased the choreic 
movement. Observation indicated a positive change in behavior of the participants, but little 
long term effect. Observation also suggested that listening to music aids in relaxation. 
Rainey Perry (1983) conducted another relevant study in 1983. Over a period of eight month 
she offered music therapy sessions to small groups (six to eight participants). She developed 
three types of sessions: (1) music and movement; (2) music and communication/relaxation; 
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Table 2  Practice Based and Quantitative Studies, Screened on Design
Author and year 
of publication
Design Setting Participants and HD-stage Goals Outcome measure Outcome results
Erdonmez-Grocke, 
1976
Clinical observational trial 
with control group
Clinical setting, individual 
treatment
N = 2 mid-stage
N = 5 late stage
Stimulation of expressive speech
Rating of 3 tests (pre-mid-post) 
through discussion tapes
No statistical evidence for 
improvement of expressive speech
Hoskyns, 1982 Observational trial 
Holiday Care facility, 
group treatment
N varied per session, stage of 
participant varied per session
Counteract anxiety and frustration, 
group participation,
encouraging relaxation, reducing 
choreic movement
Playing instruments increases 
choreic movement. Listening to 
music aids relaxation. Short term 
positive change in behavior
Rainey Perry, 1983 Observational trial
Clinical setting, group 
treatment
N = 6-8, middle to late stage
Increase/maintain participation, 
attention,awaress, interaction, 




Improvement of participation, 
communication, concentration, 
memory, relaxation, movement, 
self-esteem, self-expression and 
social interaction
Magee, 1995
Single case study, needs based 
perspective
Day care facility, 
individual treatment
N = 1 early stage
Providing emotional outlet and 
means of expression
Active participation in individual 
music therapy is recommended
Clinical setting, group 
treatment
N = 1 mid-stage
Choice making, improving 
attention, concentration, 
encouraging verbalization, 
stimulate participation, improving 
social skills, avoiding isolation
Group treatment is recommended, 
both active and receptive music 
therapy
Clinical setting, group 
treatment





Receptive music therapy in group 
setting is recommended
Thaut et al., 1999 Clinical trial Individual sessions N = 27 all stages
Velocity modulation and rhythmic 
synchronization of gait
Baseline setting, pre- and post-test 
of gait. Statistical analysis (ANOVA)
Gait speed changed using RAS, 
however synchronization negatively 
impacted in early stage
Brandt, 2000
Practice based clinical 
observational
trial
Clinical setting, individual 
treatment
HD mid- and advanced stage, 
N = 6
Reducing unwanted movements/
stimulating voluntary (wanted) 
movements
Rating videotapes of 1 session by 
2 raters
No significant evidence for reducing 
while listening to favorite song
Davis & Magee, 
2001







Music can offer opportunities for 
interaction and communication
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was to investigate the music therapy indications in this setting and to compare the findings 
with the referrals in four other specialized care HD units in The Netherlands. 
In this study, emotion, communication, and self-expression are most often mentioned as treat-
ment goals for music therapists. Goals in cognitive and physical areas are less recognized. 
Multidisciplinary collaboration is well established in most of the clinics. 
Discussion
In this study we reviewed the literature describing the effect of music therapy on improvement 
of the quality of life of Huntington’s disease patients. In doing so we specifically aimed at the 
effect of music therapy to influence (1) motor disturbances; (2) cognitive disturbances; (3) 
psychiatric disturbances; and (4) emotional/social disturbances. Furthermore we studied the 
different music therapy techniques used, the primary outcome measures and assessments 
used in music therapy with people suffering from Huntington’s disease. Subsequently we tried 
to discover a relation between these issues and the indication for music therapy, the stage of 
the disease, and the quality of life.
There seems to be a discrepancy between the indication for music therapy and the quality of 
life issues mentioned by the clients themselves (Ho & Hocaoglu, 2011). On the one hand, con-
clusions are drawn stating that psychosocial and emotional issues are most often mentioned 
as being indications for music therapy (Daveson, 2007), while on the other hand, physical and 
functional problems seem to peak throughout the different stages (Ho & Hocaoglu, 2011). 
In a later study, the focus was on the role of music in assisting patients to organize their 
responses. This indication is recognized and supported by the rationale of Davis and Magee 
(2001). Improvement of motor features during the musical intervention was, however, beyond 
the scope of their study. 
There seems to be no significant change in treatment goals between the different stages 
as far as the emotional and social themes are concerned, whereas Magee (1995a, 1995b) 
emphasizes that different goals should be met throughout the different stages. However, 
Magee bases her conclusions on observational studies in only one patient. Not the stage of 
the disease but the individual treatment goals seem to be more determinative for the music 
therapy indications. However, a relation between these two issues is plausible. 
Table 3 Music Therapy and HD: Referrals and Goals
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In two qualitative studies the indication for music therapy is discussed and categorized accord-
ing to the targeted symptoms and signs that play a part in the quality of life of patients suffering 
from Huntington’s disease. The first study conducted by Daveson (2007) details the findings 
of an audit of music therapy referrals in a specialist in-patient setting for 16 patients with 
advanced Huntington’s disease. These findings indicated that patients were most likely to be 
referred due to a need for emotional expression (n = 10; 29%), maintenance of communica-
tion skills and social relationships (n = 9; 26%). Furthermore, 14% of the referrals were due 
to occupation (n = 5), 11% to physical presentation (n = 4), 11% to behavior (n = 4). Cognitive 
factors were seldom a reason for referral (n = 3; 9%). 
The second study (Bruggen van-Rufi, 2010) details the findings of a qualitative study, con-
ducted among different members of the multidisciplinary team (n = 14) in a nursing home 
specialized in HD in The Netherlands. As in the study by Daveson (2007), the aim of the study 
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the medium of intervention (the music itself) does not have to be changed. In our opinion, 
therefore, music therapy could be a suitable non-drug intervention for improving the quality 
of life of those living with HD in every stage.
The majority of articles that examined different music therapy interventions to improve quality 
of life of people living with HD were derived from observational studies. However, it must be 
noticed that the studies were often small scaled and the number of music therapy sessions 
were limited. Therefore we plan a systematic study of the effect of music therapy in HD. 
Thaut et al. (1999) state that certain goals can no longer be met, most probably because of 
the decline of cognitive abilities throughout the different stages. This is more obvious when 
patients are given different instructions. Delval et al. (2009) confirm the difficulties with 
multi-tasking in people with HD, due to attention deficit.
The sample size of Brandt (2000) was too small (n = 6) and the study consisted of only one 
music therapy session, so no useful conclusions could be drawn. Furthermore, the type of 
music as well as the manner in which it is offered in the different interventions raises questions 
(Magee, 1995b; Brandt, 2000): would different music styles, different instruments, different 
approaches have made the difference? Unfortunately there are no comparative studies of 
how these factors influence meeting the treatment goals.
The outcome of the two aforementioned qualitative studies confirms the lack of referrals to 
music therapy due to a cognitive need. Obviously, in contrast with Alzheimer’s disease where 
cognitive decline is the primary outcome measure, this is not an indication for music therapy 
in Huntington’s disease. These findings can be supported by Leng et al. (2003) who identified 
that therapeutic interventions cannot assist with regaining cognitive abilities throughout HD 
progression. 
The findings of the two qualitative studies (Daveson, 2007; Bruggen van-Rufi, 2010) are in line 
with the role that has been highlighted within the practice literature: Music therapy can be 
used to provide a means of self-expression, social interaction, and communication. 
Conclusion and recommendation
Music therapy interventions used to improve quality of life for people with HD vary and are 
not applied optimally. In none of the studies that we reviewed quality of life was the primary 
outcome. In our opinion, this also has to do with the fact that there is no consensus about 
which items of quality of life matter most for HD-patients, or at which stage of the disease 
(Ho et al., 2009; Helder et al., 2001; Ho & Hocaoglu, 2011). Due to the changing needs of the 
patient, the treatment itself has to be adjusted to the individual needs that are important at 
that specific moment. Being alert to the patient’s signals demands flexibility from all members 
of the therapeutic team. The aim of the therapy might not be to restore or regain function, 
but rather to maintain function and provide opportunities for compensatory behavior to be 
supported, developed, and rehearsed (Thaut et al., 1999). Functional training can be combined 
with cognitive, emotional, and communicative/relational approaches. In so doing, the music 
therapist makes a link between medical and psychological treatment. Within music therapy, 
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Abstract
Huntington’s disease (HD) is a progressive, neurodegenerative, autosomal dominant disease, 
characterized by motor disturbances, behavioral and psychological symptoms and cognitive 
decline. These characteristics often result in loss of expressive and communicative skills, espe-
cially in the advanced stage of the disease, frequently giving rise to behavioral problems such 
as anxiety, irritability and apathy. Music therapy is potentially a good non-pharmacological 
intervention to improve communication skills and thus possibly reduce behavioral problems, 
leading to a better quality of life (QoL) overall.
As there is little knowledge on how music therapy may contribute to improve the QoL in HD, 
a qualitative research was conducted to gain insight: a focus group study was performed, 
following the guidelines of naturalistic inquiry and grounded theory. In three open-structu-
red group discussions, participants (six HD professionals with different experience with and 
knowledge about music therapy) were asked to reflect on what defines QoL in HD and on the 
potential role of music therapy for clients with HD. 
The results show that, according to the focus group participants, psychosocial aspects seem 
to be the most important aspects which contribute to improve QoL in HD-patients, with sense 
of security, confidence and structure being the qualifications most mentioned. Autonomy and 
self-esteem are other important QoL factors. The participants stated that the stage of the 
disease and the living conditions of the patient are crucial. Poor insight, unawareness and 
denial, all due to cognitive decline, mean that it is extremely difficult for patients to reflect 
on their own QoL. As the ability to communicate and express oneself deteriorates over time, 
music therapy could play an important role in the treatment of patients with HD in all phases 
of the disease. By providing an additional means of communication, thus enabling the patient 
to express emotions, music could be used as a mood-indicator to determine in which state 
of mind the patient is. 
This article describes six HD-clinicians’ perception of quality of life for patients with HD and 
the potential role music therapy can play in improving the QoL of patients with HD using focus 
group discussions. These insights were used to inform an empirical trial looking at the effects 
of music therapy on improving the quality of life of patients with HD.
Introduction
Huntington’s disease
Huntington’s disease (HD) is a rare autosomal dominant neurodegenerative disorder, caused 
by a mutation in the HTT-gene. This progressive disease is characterized by movement dis-
turbances, neuropsychiatric disturbances and cognitive deterioration leading eventually to a 
complete dependency for daily life activities (Roos, 2010). Once manifest, the patient’s life 
expectancy is about 15-20 years (Bates, Tabrizi, &Jones, 2014). Three clinical stages can be 
described: Stage I, in which patients develop initial symptoms but are still independent. Stage 
II, patients become more dependent as the disease progresses. Stage III is the end-of-life 
stage: patients become completely dependent for all daily life activities (Bates et al. 2014; 
Roos, 2010). 
Many patients first present with neuropsychiatric or cognitive disturbances. Affective (mood) 
disorders (e.g. depression, anxiety, apathy, irritability) and behavioral problems (e.g. obsessive 
compulsive behavior and aggression) are often observed (Duijn van, Kingma, & Mast van der, 
2007) and are recognized as being most distressing for both patients and their caregivers; they 
are often the main reason for institutionalization (Hamilton, Salmon, Corey-Bloom, Gamst, 
Paulsen, Jerkins, Jacobson, & Peavy,(2003) . Psychosocial stressors may include feelings of 
sadness and anxiety about the cognitive and physical decline and about changes in social role. 
They cause a great burden on the emotional well-being of patients with HD and their quality 
of life (A’Campo, 2012).
Verbal communication is often affected because of motor impairment of speech rather than a 
reduced desire for verbal communication (Ho, Robbins, Walters, Kaptoge, Sahakian, & Barker, 
2004). A qualitative study on communication in HD, using interviews and focus groups with 
patients, family members and professional caregivers, found that all participants acknowledged 
the need for increased involvement in social life in order to enhance communication (Hartelius, 
Jonsson, Rickeberg, & Laakso, 2010). However, the gradual deterioration of communicative 
skills contributes to a decrease in functional health and an increasing inability to participate in 
various life situations. This may have a great impact on the quality of life of the patients, often 
leading to behavioral problems (Nance, Paulsen, Rosenblatt, &Wheelock, 2011). 
Due to the progressive nature of the disease, cognitive losses accumulate throughout the 
different stages. The cognitive decline often results in behavioral problems and dysexecutive 
behavior (Ho & Hocaoglu, 2011). However, the patient’s self-image doesn’t seem to change 


































Figure 1: The four domains of health related quality of life in relation to Hungtington’s 
disease
Quality of life and Huntington’s disease 
During the last few decades, several studies have been performed with the aim of determining 
which factors matter most with regard to the QoL of patients with HD. Helder, Kaptein, Kempen 
van, Houwelingen van, & Roos, (2001) concluded that physical and psychosocial symptoms 
have a great impact on the well-being of HD-patients, the latter being more severely affected. 
The accompanying motor, cognitive and personality changes can be held responsible for this 
outcome. It should be noted that in this trial the researchers restricted themselves to assessing 
motor and cognitive disabilities of HD-patients; no depression measure was included. Ho, Gil-
throughout the stages. According to Ho, Robbins, & Barker (2006), patients with HD tend 
to underestimate consistently and persistently the degree of their dysexecutive behavior. 
There are three underlying components: cognition, self-regulation and insight. McCusker & 
Loy (2014) use the term “unawareness” when a patient’s perception of obvious disease mani-
festations and impact differ from that of observers, such as clinicians or family members. 
Unawareness (or anosognosia), also described as denial and coping mechanism, correlates 
with disease progression, disease severity contributing to it to a more significant extent than 
disease duration (Sitek, Thompson, Craufurd, & Snowden, 2014).
To date, there is no cure for HD, nor can its progress be reversed or slowed down. All treatment 
must be individually tailored, as the symptoms and signs are different for each patient and 
change over time. The goal of all forms of treatment is to reduce any discomfort and pain, 
eventually leading to improvement of quality of life (Roos, 2010). 
Quality of Life 
One of many definitions of Quality of Life (QoL) is “…an individual’s perception of his position 
in life in the context of the culture and value systems in which he lives and in relation to his 
goals, expectations, standards and concerns” (World Health Organization (WHO), 2002). QoL 
is multidimensional and includes domains that are related to physical, mental, emotional 
and social functioning and the social context in which people live (Ferrans, 2005). How these 
domains are related to patients with HD is illustrated in figure 1. 
A distinction has to be made between the term QoL and Health-related Quality of life (HrQoL). 
The first term reflects the overall status of a combination of factors: a person’s health, symp-
toms and level of physical and social functioning (Ready, Mathews, Leserman, &Paulsen, 2008). 
The latter is defined as “an individual’s perception of his or her health and health-related 
domains of well-being” (WHO). In the present study we will use the term QoL indicating the 
health-related domains. 
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and participation), but also addresses contextual factors (both environmental and personal). 
There are several disease-specific tools that measure QoL-related domains for patients with 
HD, such as the Behavioral Observation Scale Huntington (BOSH) (Timman, Claus, Slingerland, 
Schalk van der, Demeulenaere, Roos, & Tibben, 2005), the Problem Behaviour Assessment 
(PBA) (Kingma, Duijn van, Timman, Mast van der, & Roos, 2008), or the Unified Huntington’s 
Disease Rating Scale (UHDRS) (Huntington Study Group, 1996). However, these tools all have 
limitations or lack sensitivity to marginal clinical effects in the later stages of the disease 
(Timman, 2005). The UHDRS-FAP (For Advanced Patients), developed in 2013 (Youssov, Dol-
beau, Maison, Boissé, Cleret de Langavant, Roos, & Bachoud-Lévi) is more sensitive to change 
in the advanced stages of the disease. 
A disease-specific patient-reported QoL outcome measure was developed in 2012 by Hocaoglu 
et al., 2012: the Huntington’s Disease health-related Quality of Life questionnaire (HDQoL). 
The HDQoL consists of three sets of scales: (1) the primary scale representing the core factors 
underlying health-related quality of life in HD, (2) the specific scales representing clinically 
meaningful HD-specific profiles of pertinent aspects of health-related quality of life, and (3) 
the summary scale. The different scales that can be derived from the HDQoL can suit dif-
ferent clinical or research purposes. The HDQoL aims to fully capture the impact of HD on 
the everyday life of the sufferers. The HDQoL is valuable in promoting more fully informed 
decision-making in the management of HD, eventually leading to more effective treatments 
(Hocaoglu et al., 2012).
Music therapy, Huntington’s disease and other neurodegenerative diseases
The literature on the use of music therapy and its efficacy in patients with Huntington’s disease 
is limited. In a detailed literature review, Bruggen van-Rufi & Roos (2015) describe that music 
therapy interventions used to improve QoL for people with HD vary greatly. Most articles 
that were analyzed were derived from observational studies, were often small-scaled and the 
number of music therapy sessions was limited. 
In none of the reviewed studies, was QoL the primary outcome. Music therapy interventions 
vary throughout the different stages of the disease. It is not the stage of the disease but the 
individual treatment goal which seems to determine the indication for music therapy. Precise 
aims and methods in relation to the stage of the disease have not been well established. 
Since there is a paucity of literature about the effects of music therapy in HD-patients, 
it is justified to search for such effects in other, similar neurodegenerative diseases, especially 
bert, Mason, Goodman, & Barker, (2009) conclude that depressive mood and functional ability 
are critically linked to QoL in HD. This outcome is underlined by Ready et al. (2008) who state 
that depression is a strong predictor of QoL in HD and that motor impairment, independent 
functioning and cognitive impairment had lesser yet significant associations with QoL. When 
focusing on the QoL and HD, there is reason to suspect that neuropsychiatric symptoms are 
particularly harmful. These symptoms are common in HD and include high rates of depression, 
suicide, obsessive compulsive disorder and personality change. Also, psychopathology tends 
to be more severe in HD (Ready et al., 2008). 
In 2011, the European Huntington’s Disease Network (EHDN) Quality of Life Working Group 
initiated a qualitative research on the impact of HD across the entire disease spectrum (Ho 
&Hocaoglu, 2011). Semi-structured face-to-face interviews were individually conducted with 
31 persons living with different stages of HD, from pre-clinical gene carriers to advanced stage. 
Physical and functional decline peaked throughout the different stages, indicating that these 
issues were raised more frequently by the patients over the course of the disease. There 
were no significant changes between stages for the emotional and social domains. Cognitive 
impairments were only raised in the early and middle stages. In the advanced late stage, 
the cognitive impairments hardly featured any more. As mentioned previously, the patient’s 
self-image is most probably the cause of this contradiction; it is the degree of cognitive impair-
ment which affects insight at this stage. Also, in the late stages, the physical impairments 
became increasingly evident which makes determination of the cognitive, emotional and social 
domains extremely difficult (Ho &Hocaoglu, 2011).
Until a decade ago the QoL of patients with HD could only be assessed using generic QoL-mea-
surement scales (Helder et al., 2001), (Hocaoglu, Gaffan and Ho, 2012). These generic tools are 
unlikely to capture the total and true impact of the more specific and unique consequences 
of HD, particularly the many non-physical aspects of the disease.
There has been little consistency in QoL models within the literature in the past 10 years. 
Providing an overview of the many concepts is beyond the scope of the present study. How-
ever, in the process of finding the concepts that best describe QoL in HD, the World Health 
Organization International Classification of Functioning, Disability and Health-model (WHO-
ICF) is worth mentioning (WHO). This model is not specific to measuring HrQoL, it is more 
a mapping and classification framework than a guide for hypothesis generation in the area 
of HrQoL (Bakas, McLennon, Carpenter, Buelow, Otte, Hanna, Ellett, Hadler, & Welch, 2012). 
This model focuses on functioning (body-functioning and structures) and disability (activities 
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the experience of pleasant emotions. Through music, contact can be established, especially 
as language deteriorates during the later stage of the dementing process (Vink, 2013). 
In a “state-of-the-art”-article on music therapy and Parkinson’s Disease, Raglio (2015) 
concludes that interventions that involve music can offer important starting points in PD 
rehabilitation, effectively acting on motor, as well as non-motor symptoms. Although only a 
limited number of studies take the psychological outcome into account, an earlier research by 
Pacchetti, Mancini, Agilieri, Fundaro, Martignoni & Nappi (2000) showed a significant overall 
effect on motor improvement and beneficial effects on emotional functions, activities in daily 
living and quality of life. They concluded that MT is effective on motor, affective and behavioral 
functions. 
In general, throughout the literature on music therapy and neurological disorders it is sug-
gested that researchers need to focus on the remaining abilities of patients rather than 
focusing on the abilities that are diminishing (Van Beek, 2012). In a trial where the cognitive 
burden in HD is explored throughout the different stages, Papoutsi, Labuschagne, Tabrizi, & 
Stout (2014) support this idea by stating that “…enhancing cognitive reserve through cogni-
tive interventions is very promising, because these interventions are noninvasive and readily 
available to be used (…) together with other more invasive therapeutic approaches for later 
disease stages. Such research has been limited thus far in HD (…) HD would be an ideal model 
to test such methods...” (Papoutsi, Labuschagne, Tabrizi, & Stout, 2014), p. 680). 
Elaborating on this assumption, we decided to develop a focus group study to explore if music 
therapy could be such an intervention. The main purpose of the present study was to describe 
the perceptions of different HD-clinicians on music therapy. Understanding these perceptions 
will help us gain insight in the potential role the music therapist can play in the multidisciplinary 
team surrounding patients with HD.
dementia in general, dementia of the Alzheimer’s disease (DAT) and Parkinson’s disease (PD). 
Since the prevalence of these diseases in today’s society is much larger than HD, there has 
been more extensive music therapy research into DAT and PD. However, comparison with 
these disorders needs to be done with some caution as these conditions have different impacts 
on the brain and central nervous system.
HD has some similarities with dementia and PD in that these disorders cause the brain, as in 
HD, to deteriorate progressively, affecting mental, cognitive and motor functions. Dementia 
(loss of mental abilities) is common in neurodegenerative disorders (Liou, 2010). Dementias 
are often classified by the region of the brain that is affected. PD and HD are sub-cortical based 
and AD is cortical based. Although this classification is rather controversial among researchers 
and physicians, some differences do exist, but there is disagreement on the degree of dif-
ferences. Cortical dementia (AD) has more impact on semantic and episodic memory while 
patients with sub-cortical dementia (HD and PD) do not experience degradation of semantic 
memory per se; they find it challenging to accomplish cognitive tasks that require retrieval, 
but this will improve under the right conditions (i.e. being “cued”) . Furthermore, sub-cortical 
dementias almost always result in motor disorders. In terms of cognitive effects, differences 
between dementias are still being studied (Liou, 2010). 
The literature provides us with useful conclusions from scientific research investigating the 
benefits of music therapy with dementia and PD that may also apply for HD.
Music therapy provides stimulation and may help to prevent social isolation for elderly individ-
uals suffering from more advanced dementia. If words are no longer recognized, familiar music 
may provide a sense of safety and well-being, which in turn may decrease anxiety (Brotons, 
2000). Listening to music is significantly more effective in increasing levels of engagement and 
well-being than not being exposed to music, regardless of the level of cognitive impairment 
in people with slight to severe dementia (Sheratt & Thornton, 2004). In an in 2011 published 
updated Cochrane-review, an overall beneficial effect of music therapy with dementia could 
not be supported, but positive effects were found specifically in decreasing problem behavior 
(Vink, Bruinsma, & Scholten, 2011). In the recently update Cochrane review on music-based 
therapeutic interventions for people with dementia the authors conclude that music therapy 
may reduce depressive symptoms (Steen van der, Soest van-Poortervliet, Wouden van der, 
JBruinsma, Scholten, & Vink, 2017). Music therapy can decrease agitation and has a positive 
effect on enhancing communication and emotional well-being (Vink, Zuidersma, Boersma, 
Jonge de, Zuidema, & Slaets, 2012). Music therapy enables the recall of life experiences and 
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all working in The Netherlands but each in a different care facility specialized in HD-care, so 
none of them were direct colleagues. One participant had a working relationship with the 
principal researcher (the first author). The average age of the participants was 46 years and 
the average number of years of expertise with HD-patients was 15 years. Apart from the 
two music therapists, one participant had much clinical experience with music therapy, one 
had little experience and two had no experience at all. All six respondents had experience in 
scientific research: two of them had a PhD-Degree, two had a Master’s Degree and two had 
a Bachelor’s Degree. 
Prior to the first meeting, the first author of this article visited all the participants separately 
and gave them extensive verbal and written information about the aim of the research, the 
methodology and the protocol. She handed out a topic guide in which she revealed the main 
topics of the discussions. The topic guide consisted of several articles about QoL (Helder et al., 
2001, Ho et al., 2009 and Ho et al., 2011) and about music therapy (Bruggen van - Rufi, 2009 
and 2010). She instructed all participants to read these articles before the first meeting, giving 
each participant the same level of knowledge to use as a starting point for the discussions.
Moderator and assistant moderator
The discussions were guided by a moderator. The moderator did not participate in the dis-
cussion itself but raised issues and encouraged participants to reflect on topics openly. She 
summarized what had been said during the discussion. The moderator was completely famil-
iar with the questioning route and knew the rationale for each question (Krueger, 1997). An 
assistant moderator was also present to make sure all the equipment worked correctly and to 
make notes. After each meeting the moderator and the assistant evaluated the notes taken. 
Procedure Data collection
We conducted a total of three focus group meetings lasting two hours, followed by a telephone 
call made by the moderator to each participant to enable them to reflect on the last (third) 
group meeting. The three research questions (see above) were the guideline throughout all 
three meetings and all topics were open to discussion. 
The group-discussions were audio-recorded once all the participants had given informed con-
sent. The recordings were transcribed verbatim by either the assistant moderator or the first 
author. Prior to each meeting, the participants were asked to write down their thoughts about 
the topics to be discussed. These papers were handed to the moderator and were accounted 
for in the analysis. Furthermore, notes were taken during each session by both the assistant 
Method
The focus group method is a qualitative research method to collect data using guided group 
discussions in order to generate a rich understanding of participants’ experiences and beliefs. 
The discussions create a process of sharing and comparing among the participants, investigat-
ing issues of context and depth, and generate their own interpretations of the topics (Morgan, 
1998). Powell & Single (1996) state that the focus group method is appropriate if 
- a certain topic is very complex (as is QoL) and needs to be explored from different points 
of view. 
- a large number of variables needs to be reduced to the most essential ones; since QoL is 
such a wide concept, the question what matters most in QoL was discussed extensively. 
- little is known about a certain topic (music therapy to improve QoL); the focus group 
method has an explorative character and generates hypothesis. 
Guidelines of two methods were followed: the naturalistic inquiry (Lincoln & Guba, 1985) and 
the grounded theory (Glaser & Strauss, 1967). The first is a method in which a series of techni-
ques is used to conduct qualitative research. Using these techniques, the method emphasizes 
the trustworthiness of the trial, which is important in evaluating its value. 
The second is a systematic methodology that is used to construct a theory through the analysis 
of data. On reviewing the collected data, recurring ideas and concepts become apparent. As 
more data are collected and reviewed, concepts become categories which form the basis for 
new theory. 
The three main research questions were:
Based on your own clinical experience
- what is QoL in general for patients with HD?
- what are the most important aspects of QoL in patients with HD?
- Could music therapy play a role in order to improve QoL in patients with HD?
These questions were continuously repeated during all three meetings. 
Participants
Six HD-professionals specialized in five different treatment areas participated in the study. 
They were recruited by way of homogeneous purposive sampling: they were chosen because 
of their rich clinical experience with HD. The sample consisted of one neurologist, one elderly 
care physician, one psychologist, one physical therapist and two music therapists. They were 
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Throughout the whole analysis process the codes and (sub)categories were checked with 
the moderator. The participants received a summary of every meeting, describing the (pre-
liminary) analyses and highlighting the key findings. They were asked to check the content 
(member check/member validation), in certain instances resulting in modifications (negotiate 
outcomes).
Results
The results presented below first describe the participants’ perceptions of 
- QoL in general for patients with HD the most important aspects of QoL in patients with HD
- Subsequently, elaborating on the results of the first two research questions, the partici-
pants’ perceptions on the third research question will be presented:
- the potential role of music therapy in improving QoL in patients with HD.
In the discussion we will expand on these interpretations in more depth, reflecting the par-
ticipants’ perceptions, tying together their ideas with the rationale for music therapy with 
patients with HD from the literature. 
Q: What is QoL, based on your own clinical experience?
Analysis of the verbatim transcripts revealed several themes and subcategories (see fig. 2) 
which are presented below, illustrated with the most distinct quotes, accompanied by a short 
interpretive summary. 
In each of the three sessions, the participants cited a number of items. The one theme being 
mentioned most often was the subjectivity of QoL: 
“…One patient can have a very low self-esteem because his involuntary movements are 
so conspicuous. Another patient doesn’t mind that his motor functions are poor, as long 
as his cognitive skills are still good. No matter how badly a person moves, he can still feel 
good about himself... ” 
 “…the only person who can say something about it is the patient himself. We, the profes-
sionals, can only ask, or guess…”
A typical comment where all participants agreed upon was that patients have difficulties 
reflecting about their own QoL due to the cognitive decline. Besides that, one of the partici-
moderator and the moderator. After the third meeting, no new themes seemed to emerge, 
leading to the conclusion that data saturation had been reached. 
Trustworthiness
 To ensure credibility and trustworthiness (two evaluation standards that are characteristic for 
the naturalistic inquiry approach), we used the following procedures:
Triangulation, member check, peer debriefing
We used different methods of data collection: focus group discussions and notes taken during 
the discussions (methodological triangulation). Also, as a form of data triangulation, prior to 
each meeting the participants were asked to write down their thoughts about the topics to 
be discussed, thus producing a written record of each participant’s thoughts. Should time 
restrictions prevent them from expressing their thoughts during the meeting, these could 
still be accounted for in the analysis (authenticity). From the second meeting onwards, the 
moderator started by confirming that everybody had received the summary of the previous 
meeting and had been afforded the opportunity to give their comments, thus ensuring that no 
important information was missing and that they recognized themselves in the conclusions so 
far (confirmability, member check). During the analysis, the moderator examined the analysis 
process and records for accuracy (confirmability). All three audit reports were shared with 
all participants. These reports can be provided upon request. Furthermore, the preliminary 
results were presented and discussed with music therapists and neuroscientific researchers 
at an international music therapy congress (poster and oral presentation) (peer debriefing). 
Here, they challenged the interpretations of the data and the preliminary conclusions of the 
focus group study. Their objective feedback was used to finalize the conclusions of the study.
Analysis
The verbatim transcripts were analysed by the first author. The themes and concepts were 
derived from the data by using the open coding system: the descriptions used by the partici-
pants during the discussion were identified and codes that described the same themes were 
clustered or deducted. A content analysis was performed according to the constant compari-
son method, based on the grounded theory of Glaser & Strauss (1967). Data were extensively 
collected, coded and organized. In this approach the process of induction (determining what 
premises can logically be derived from the emerging themes) leads to deduction (what else 
would have to be true if these premises are true). The whole process of constant comparison 
leads to general conclusion(s) which can logically be derived from the data (Boeije, 2005), 
(Copi, Cohen & McMahon, 2015). 







































































Figure 2: (sub)categories and emerging themes
pants felt that patients do not express themselves in QoL-terminology, because in his opinion, 
QoL is a term used by the professionals, who must listen beyond what has actually been said 
and “translate” it into QoL-issues. All participants agreed that this “translation” might not fully 
reflect the patient’s perception of his own QoL, as it is the interpretation of the professional. 
Elaborating on this, another comment was that the professionals tend to be too protective 
towards the patients: 
“…Life consists of ups and downs, that is part of life. We cannot and must not protect our 
patients from that…”
All participants agreed that recognition of the individual needs of the patient is most impor-
tant when thinking about his QoL. They all emphasized that functionality and autonomy of 
the patient himself must be maintained and supported as long as possible. Involving family 
members in achieving this was also recognized by all participants as being very desirable. 
One of the participants who is involved with patients at the earlier stage of the disease, before 
admission to a nursing home, or even before onset of the symptoms, stated: 
“…Quality of life is not an issue that is raised frequently in the doctor’s office because the 
doctors have only little to offer in that aspect. The emphasis should be on care, and not 
on cure…”
Following this statement, the discussion continued more specifically in the direction of QoL 
and the disease itself.



















Figure 4: Consequences of cognitive decline i.r.t. self-reflection
Stage of the disease and cognitive decline
All participants agreed that the stage of the disease and the cognitive decline are inextricably 
related. The cognitive deterioration becomes more distinct as the disease progresses. All par-
ticipants recognized the patient’s inability to reflect about his own QoL. Denial, poor insight 
and poor coping skills were mentioned as the most debilitating factors in being able to do so 
adequately: 
“…in the earlier stage of the disease, the patient tends to deny the symptoms and signs 
while in the later stage the patient can no longer reflect about it...” 
“…Denial comes from the patient himself, while poor insight is a result of cognitive decline 
in the later stage of the disease. Self-image does not grow with the progression of the 
disease, often resulting in behavioral problems...” 
One participant shared her experience with the group: when asking the patient about how he 
feels, he will often score himself “average” on a rating scale, adjusting to new circumstances. 
 “…Everybody has his own highs and lows, no different in patients with HD. The average 
will always be in the middle…”
The discussion that followed, as one of the participants raised the question how HD-patients 
react differently from (healthy) persons in certain circumstances, focused specifically on the 
Q: What are the most important aspects of QoL in patients with HD?
The content analysis of the transcripts revealed that, according to all participants, psychosocial 
and cognitive symptoms influence QoL most. Three major themes were identified: stage of 
the disease (1), cognitive decline (2) and circumstances/living conditions (3). While discussing 
these major themes, three subcategories emerged: (sense of) security (a), confidence (b) and 
structure (c). 
In fig. 2 the findings are summarized in subcategories under each theme. How the subcatego-
ries relate to the three major themes is illustrated in fig. 3. In fig. 4, the consequences of the 
cognitive decline in relation to self-reflection about QoL is highlighted. Together they form an 

























Figure 3: Relation subcategories and major themes
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“…it takes very much time for a patient with HD to build trust. The more knowledge and 
affinity you have, the sooner this trust is a fact. This is an absolute necessity to treat the 
patient effectively…”
However, once admitted to a LTCF, autonomy, self-esteem and future perspectives for the 
patient are QoL issues which are raised more often. The discussion continued while reflecting 
on these emerging themes: 
“…each new situation results in severe tension and stress. Processing new information is 
extremely difficult, due to cognitive decline of the disease in the later stages...”
“…the patient sitting in front of us is someone who still wants to be heard. A person with 
needs and wishes like all other human beings...”
When autonomy is jeopardized, the participants agreed that living in a LTCF specialized in care 
for HD-patients is most desirable. They will find themselves surrounded by specialists, resulting 
in an improved feeling of security and confidence. 
“...Even though the patient might not want to be here, he feels at ease, safe. All the people 
around him, fellow patients and nursing staff, know what he is going through…”
When no more new emerging themes seemed to be raised by the participants, the monitor 
summarized the results so far of the group discussion. While all participants recognized that 
the subjective nature of the QoL-concept requires self-report by the patient for as long as pos-
sible, it was agreed that this becomes more and more challenged due to disease progression. 
When the HD-patient loses his ability to express himself in the later stage of the disease, other 
means of communication should be provided. The monitor used this conclusion to introduce 
the last and foremost important question, encouraging the participants once again to reflect 
open minded and freely:
Q: Can music therapy play a role in improving QoL in patients with HD?
Before going into the different themes, it is worth mentioning that some general yet distinc-
tive “opening”-thoughts were shared by some of the participants on which the rest of the 
discussion elaborated:
cognitive decline of patients with HD. 
One of the participants commented that the cognitive decline can be beneficial for the patient:
“…it can be a relief for the patient as he is no longer aware of his decline. He is coping with 
and adjusting to his new situation…”
Following this comment, the participants agreed that the cognitive decline results in yet ano-
ther paradox: the impact of the disease seems to be less of a burden for the patient than for 
the people around him. This can cause much stress, especially when patients still live at home. 
All participants agreed that family support is very important. More specifically, they agreed 
that all people surrounding the HD-patients must have a comprehensive knowledge of the 
disease in order for the patient to feel confident and secure. 
The discussion continued with these emerging themes on security, confidence and structure. 
One of the participants stated that 
“…sense of security and confidence come from within the patient himself; structure must 
be provided by the people around the patient. The conditions and circumstances he lives 
in must be created by the people surrounding him…” 
This statement resulted in the unanimous recognition that another important distinction has 
to be made: Is the patient still living at home, does he receive daily care from family members, 
does he visit a day care facility or is he living in a long-term care facility. 
Circumstances/living conditions 
As the cognitive decline affects the patient’s ability to structure his own life as the disease pro-
gresses, he becomes more and more dependent on his surroundings. One of the participants 
shared his perception with the group by commenting that
“…structure is the basis of feeling safe. We have to make sure that patterns, rituals, eve-
rything that the patient is used to, continue every day…” 
Following this comment, the discussion continued with reflecting about structure. 
Participants agreed that structure seems to be best secured by living in a long-term care facility 
that is specialized in HD care because of the specific expertise these facilities have. 
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Another participant added:
“…Within music therapy the patient can express himself both non-verbally (playing musical 
instruments) and verbally (writing song lyrics, listening to existing songs and reflecting 




Following these thoughts, the discussion continued when a new theme emerged: the use of 
music as a mood indicator. Some of the participants shared their own personal experience with 
music. Another participant who has no affinity with music whatsoever shared her thoughts as 
well, directing the discussion about the benefits of music in both positive and negative ways. 
However, putting their own personal thoughts about music aside, all participants agreed that 
for some patients music could be helpful. 
One of the participants recognized the potential role of music, stating that 
“…music could be used as an indicator to determine in which state of mind 
a patient is...”
 
“…in music therapy the patient can create his own song, record it and give this to his family 
members. In this way the family could not only recognize the mood the patient is in, but 
also the person behind the patient, the partner or the father he once was, and still is or 
wants to be…”
The participants agreed that even though the patient might no longer be able to reflect on 
the state of mind he is in, his choice of music or his reaction to the music played for him might 
help him express his feelings and help the people around him understand the patient better.
This last thought led the discussion to yet another emerging theme:
Involving family members
In relation to improving the QoL, all participants agreed that involving the direct family mem-
bers or other caregivers is desirable.
“…as long as there is still no medication to cure the disease we should try every possible 
(non-pharmacological) intervention and treatment. Music therapy could very well be one 
of them (…), well worth giving it [MT] a try…”
Elaborating on the aforementioned themes that emerged from the first two QoL-questions, 
three major themes were found: new ways of communication and expression, mood-indicator 
and family-participation (see fig. 5). Below, the participants’ perceptions on these themes will 






















Figure 5: Potential roles of music therapy
Communication and expression
One of the participants felt that if a person loses the ability to communicate with others, 
music could take over:
“…music could be a new way to communicate again and to come to the inner self of the 
patient, to his emotions. The non-verbal character of music allows the patient to express 
himself in a different way (…) when a person can no longer give words to his feelings, music 
can give him new ways of expressing himself…”
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The patient should feel secure, safe and confident. Sense of security and confidence are 
intrinsic factors and come from within the patient himself. However, structure in his daily life 
and the conditions and circumstances in which he lives seem to be decisive and are extrinsic 
factors which must be provided by the people surrounding the patient. In short, interaction 
between patient and caregiver is crucial, inevitably causing yet another area of stress (Vervoort 
& Zuuren van, 2009).
Determining which aspects are most important with regard to the (health-related) quality of 
life of patients with Huntington’s disease is hindered by the many debilitating factors surround-
ing the patient, both physically and psychologically. 
Because of this, it is justified and common to rely on the report of the caregivers and other 
proxies of the HD-patient, even though “…the subjective nature of the concept of QoL requires 
its assessment to be carried out by self-report where possible…” (Hocaoglu et al, 2012, p. 
1793). 
There is, however, the risk of being too paternalistic and overprotective. McCusker & Loy 
(2014) state that “…the primary ethical dilemma for all care providers is the balance between 
a patient’s family’s concern regarding care and safety and maintenance of the patient’s auton-
omy, privacy and engagement…”(p. 6).
Relying on proxies presents another dilemma to be taken into account: many people with seri-
ous and persistent disabilities experience a good or excellent quality of life, while to external 
observers it seems these individuals live an undesirable daily existence. The impact of the 
disease appears to be less of a burden for the patient than for the people around him. This 
so-called disability paradox can also be recognized by people with HD (Albrecht & Devlieger, 
1999). 
In short, the different perceptions about QoL of the focus group participants are consistent 
with the literature. While there are many debilitating factors that influence the QoL in HD, it 
is important to find a concept that best describes all these disease-specific issues. 
As detailed previously, the discussion about the potential role of music therapy in improving 
QoL for HD-patients resulted in three major themes: new ways of communication and expres-
sion, mood-indicator and family-participation (see fig. 5). These findings are consistent and 
can be confirmed with the music-therapy literature. 
“…the family relation between the patient and his partner and/or his children can be rein-
forced through music therapy…”
“…within music therapy partners could relive good experiences from before the disease 
kicked in hard (…) but also they can experience what is still there...”
“…music therapy could be a resource to give a positive change to an often problematic 
relationship. The healthy partner can recognize the “old” partner again...” 
Discussion 
This study is a first attempt to highlight the different opinions of a heterogeneous group of 
experienced professionals about quality of life in (advanced) Huntington´s disease, and the 
possible role music therapy could play. The main purpose of the research was to describe dif-
ferent clinicians’ perceptions of music therapy in improving the quality of life in patients with 
Huntington’s disease. Six professional clinicians from varying disciplines, all specialized in HD, 
discussed three major themes: QoL in general, QoL in HD and music therapy for HD-patients. 
In the discussion below we will first expand on the participants’ perceptions about QoL, tying 
together their ideas with the literature. Subsequently we will do the same for the perceptions 
of the participants about music therapy.
In general, it was stated that reflecting about a patient’s QoL, when he is incapable of doing so 
himself (as is the case in most HD-patients, especially in the later stages), is extremely difficult, 
given the subjective nature of the topic. Participants agreed that functionality and autonomy 
of the patient are the most distinct QoL-factors. When focusing on QoL of HD-patients, psy-
chosocial and cognitive symptoms seem to influence QoL most. Stage of the disease, cognitive 
decline and the circumstances/living conditions of the patient are being recognized as the 
most important determinants of QoL. 
Furthermore, HD-patients face many psychological issues such as anxiety, stress and hope-
lessness. Once their symptoms have become manifest, the patients realize their future 
perspectives, which has an immense impact on their QoL. As a result of the inability to express 
oneself due to the lack of (verbal) communication skills, it is highly likely that psychosocial 
problems will occur (Vervoort & Zuuren van, 2009). 
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Although the literature shows that precise aims and methods in relation to the stage of the 
disease are not well established yet (Bruggen van-Rufi & Roos, 2015), the focus group results 
suggest that music therapy may be beneficial throughout the various stages. Music ther-
apy can combine functional training with cognitive, emotional and communicative/relational 
approaches. In so doing, the music therapist can forge a link between medical and psycholog-
ical treatment. Methods and techniques can be constantly adapted, guided by the individual 
treatment goals of the patient, bearing in mind all of his or her limitations and skills. In short, 
the sessions can be “tailor-made” to the patient and his needs (Bruggen van-Rufi & Roos, 
2015). 
 
Strength and limitations 
The strength of our study lies in the richness of experience of our participants. Collaboration 
with other professionals is imperative in order to meet the patient’s needs. Except for the 
two music therapists, all participants came from different disciplines, and each was working 
in a different health care institution. Also, all of them had many years of experience with 
Huntington patients and had experience with or knowledge about scientific research. They 
represented the well-being of the patient with HD in every aspect. Furthermore, the number 
of participants was small enough to allow us to examine their responses in depth. They needed 
little encouragement to describe their experiences in detail. 
At the same time however, having only six professionals participating in the study is a major 
limitation. Although the participants contributed a variety of different opinions, different issues 
might have been raised if more clinicians would have participated. Also, all participants were 
from The Netherlands. It is possible that clinicians from other countries may have different 
opinions, especially because long term care facilities (LTCF) where only HD-patients reside are 
not so common outside The Netherlands. 
Another weakness of the research might have been the involvement of two music therapists 
with the four other clinicians who may have felt inhibited by their presence to provide nega-
tive views about music therapy. The reason for this was to make sure that at least one music 
therapist would be present at every session, anticipating possible absence of one of them. We 
cannot rule out the possibility that both music therapists were, unintentionally, advocating 
the use of music therapy during the group discussions, or stimulated socially desirable ans-
wers. We tried to minimize this by instructing them beforehand not to advocate but to inform 
about music therapy. This was a pragmatic choice, however we are well aware that instructing 
participants is contradictive for the naturalistic method. This is another weakness in the study.
Communication and expression
Improving communication skills of individuals have been frequently reported in music ther-
apy (McFerran, Lee, Steel, & Bialocerkoswki, 2009, Bruggen van – Rufi, 2009). As the ability 
to communicate and express oneself deteriorates over time, music therapy could play an 
important role in the treatment, in that it could provide an additional means of communi-
cation. The results from a music therapy referral audit conducted by Daveson (2007) show 
that patients with HD were most likely to be referred to music therapy due to a need for 
emotional expression, and the maintenance of communication skills and social relationships. 
This outcome can be confirmed by Bruggen van – Rufi (2010) who interviewed 14 members 
of the multidisciplinary team in a nursing home specialized in HD in The Netherlands. In this 
research, too, communication and self-expression were mentioned most often as treatment 
goals for referral to music therapy. 
Mood indicator
Due to the affective (mood) disorder that is often manifested in the later stages of the disease, 
people suffering from HD have a diminished ability to recognize and express emotions, both 
in themselves and in others. Music and emotion seem to be inextricably connected (Juslin & 
Sloboda, 2010). Musical experiences can empower people to feel that they are alive and also 
promote shared experiences with others (McFerran et al., 2009).
Family participation
Music therapy can be offered both individually and in group sessions, with fellow-patients 
and with family members (Bruggen van-Rufi & Roos, 2015). As the focus group stated that 
involving family is of prime importance, the beneficial role of music therapy can be confirmed 
by McFerran et al, 2009; they conclude that using music therapy interventions to help improve 
communication skills with their carers outside of the music therapy sessions will be the most 
beneficial outcome.
In conclusion, because of the changing needs of the HD-patient, inherent to the stage of the 
disease, the treatment itself has to be adjusted to the individual needs important at that 
specific moment (Davis & Magee, 2001, Daveson, 2007). In HD the stage of the disease is 
crucial; while in the early stage denial might be an issue, in the middle and late stages poor 
insight into the disease itself might be the reason why QoL issues are raised less frequently 
by the patient. In the later stage of the disease, the patient might no longer be able to reflect 
about his own QoL. 
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Future prospects
Until recently, there was a lack of a disease specific measurement tool to assess music therapy 
with HD. Such a tool, the Music therapy Assessment Tool for Advanced Huntington’s Disease 
(MATA-HD), has now been developed. The results of a pilot study to validate this tool were 
recently published (O’Kelly & Bodak, 2016). Preliminary data indicate that the MATA-HD is a 
promising tool for measuring patient responses to music therapy interventions across psycho-
logical, physical, social, and communication domains of functioning in patients with advanced 
HD. 
Conclusion
The results of the present focus group study suggest that music therapy can target many facets 
that are important to the QoL of patients with HD. As the ability to communicate and express 
oneself deteriorates over time, music therapy could play an important role in the treatment 
of patients with HD in all phases of the disease. Through music therapy an additional means 
of communication can be provided, enabling the patient to express his or her needs and 
emotions. Also, music can be used as a mood-indicator. Finally, involving family members 
in the treatment is desirable and should be encouraged. In music therapy this can be easily 
accomplished .
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The results obtained in this research must be regarded in the light of some more limitations. 
First of all, the participants were all acquainted with the main researcher and were aware 
of her ideas about setting up a music therapy research for HD-patients. For this reason, the 
researcher herself was never present at the meetings, nor talked about the trial while meeting 
the participants on different occasions. 
Also there could be concern that the “must-read-articles” about music therapy, written by 
the main researcher, could have influenced the participants and led them to be more positive 
about music therapy and to conceal their criticism about music therapy. 
Another weakness of the study was that in the first two meetings not all participants were 
present. However, the absent members were all given sufficient opportunity to participate in 
the group discussions by inviting their comments on the preliminary reports of each meeting, 
sent to them prior to the next session. At the start of the next meeting, those who had been 
absent from the previous meeting were given the opportunity to ventilate their thoughts. All 
participants were present at at least two of the three meetings.
Finally, in the attempt to find a representative and homogeneous sample where participants 
had a certain comparable level/degree of (scientific) experience, expertise and knowledge, we 
decided not to involve patients, caregivers or nurses. The results of this research reflect the 
opinions of professionals, not of the patients or caregivers themselves. Taken the aforemen-
tioned pitfalls into account (unawareness, disability-paradox, etc.), an additional focus group 
study in which patients and caregivers are the participants is recommended.
Although over the last few decades there has been an increasing number of clinical trials 
focused on the search for new therapeutic (pharmaceutical) strategies to manage HD, unfor-
tunately few advances have been made. While there is still no cure, the emphasis should be 
on the care of patients with HD, especially in the advanced stage of the disease (Roos, 2010). 
Contributing to this need, a multi-center randomized controlled trial studying the effect of 
music therapy in Huntington’s disease to improve the quality of life of patients with HD, by way 
of improving communication skills, was conducted from October 2014 until June 2016 in four 
different long term care facilities in The Netherlands (Bruggen van – Rufi, Vink, Achterberg, 
& Roos, 2016). The results of the present focus group study helped informing this RCT. Final 
results of this study are expected in the winter of 2017. 
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“After silence, 
that which comes nearest to expressing 
the inexpressible is music”
Aldous Huxley (1894 – 1963)
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Abstract
Background: Huntington’s disease is a progressive, neurodegenerative disease with autosomal 
dominant inheritance, characterized by motor disturbances, cognitive decline and behavioral 
and psychological symptoms. Since there is no cure, all treatment is aimed at improving quality 
of life. Music therapy is a non-pharmacological intervention, aiming to improve the quality 
of life, but its use and efficacy in patients with Huntington’s disease has hardly been studied. 
In this article, a protocol is described to study the effects of music therapy in comparison with 
a control intervention to improve quality of life through stimulating expressive and commu-
nicative skills. By targeting these skills we assume that the social-cognitive functioning will 
improve, leading to a reduction in behavioral problems, resulting in an overall improvement 
of the quality of life in patients with Huntington’s disease. 
Methods/Design: The study is designed as a multi-center single-blind randomised controlled 
intervention trial. Sixty patients will be randomised using center-stratified block-permuted 
randomisation. Patients will be recruited from four long-term care facilities specialized in 
Huntington’s disease-care in The Netherlands. 
The outcome measure to assess changes in expressive and communication skills is the 
Behaviour Observation Scale Huntington and changes in behavior will be assessed by both 
the Problem Behaviour Assesment-short version and the BOSH. Measurements take place at 
baseline, then 8, 16 (end of intervention) and 12 weeks after the last intervention (follow-up).
Discussion: This randomized controlled study will provide greater insight into the effective-
ness of music therapy on activities of daily living, social-cognitive functioning and behavior 
problems by improving expressive and communication skills, thus leading to a better quality 
of life for patients with Huntington’s disease.
Background
Huntington’s Disease (HD) is a progressive, neurodegenerative disease with autosomal 
dominant inheritance, caused by an elongated CAG repeat on chromosome 4 [1]. HD is char-
acterized by motor disturbances, cognitive decline and behavioral and psychosocial symptoms. 
The cognitive disorder in HD effects a broad variety of skills, including learning and memory, 
perceptual skills, executive efficiency and language [2]. Cognitive and behavioral changes are 
the most debilitating aspects of the disease and place the greatest burden on the patient as 
well as on their families and caregivers, and are often the main reason for institutionalization 
[3, 4]. Affective (mood) disorders (e.g. depression, anxiety, apathy, irritability) and behavioral 
problems (e.g. obsessive compulsive behavior and aggression) are frequent symptoms [5]. 
Verbal communication is often affected, due to motor impairment of speech. In addition, as 
a result of the cognitive decline, word retrieval is often impaired, although the knowledge 
of vocabulary is retained. As the disease progresses, the language content can no longer be 
processed properly and in the later stages of the disease, a patient with HD might not be able 
to communicate adequately [1].
As a result of the communication problems, patients are no longer able to express themselves. 
Revealing the patients’ unmet needs is, therefore, hindered and this might lead to irritability, 
impulsive and unwanted behavior (frequently signs in HD), causing much distress for patients 
and caregivers. Because of the behavioral symptoms, cognitive decline and the inability to 
express oneself, psychosocial problems develop [6]. Psychosocial stressors may include feel-
ings of sadness and anxiety about the cognitive and physical decline, and about changes in 
social roles [7]. The gradual deterioration in communication skills, in combination with the 
behavioral problems in patients with HD, contributes to a decrease of functional health and a 
progressive inability to participate in various life situations, leading to loss of quality of life [8].
 
Since there is no cure for HD, the aim of all therapy, both pharmacological and non-pharma-
cological, is to improve quality of life [3]. One form of non-pharmacological intervention is 
music therapy. 
Music therapy uses music experiences and patient-therapist relationships in order to effect 
therapeutic change [10]. Over the past decades, music therapy has been developed for 
patients with neurodegenerative diseases [11,12]; its efficacy is shown in table 1. 
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To test this hypothesis, we wrote a study protocol to answer the following questions:
1. Does music therapy improve expressive and communicative skills in people with HD?
2. Does music therapy reduce behavioral problems in patients with HD?
3. Does music therapy improve the quality of life of patients with HD? 
METHODS
Study design
The study is a multi-center, single-blind, randomised controlled intervention trial with two 
parallel arms. An overview of the study design is shown in a flow chart (see figure 1). It is 
single-blinded; the researcher who analyses all the scores is unaware of the allocation of the 
patients throughout the study. Also, the persons performing the baseline-assessments will be 
kept unaware of the allocation of the participants they are testing. Sixty patients (see sample 
size calculation below) will be randomised using center-stratified, block-permuted randomi-
sation following the procedure as described below. Two random groups will be created. The 
experimental group will be offered a music therapy program according to a structured protocol 
(see below), and the control group will participate in recreational day activities, following the 
same protocol as the experimental group. In addition, both groups will receive regular treat-
ment (standard care, treatment as usual). Participants from both the experimental and the 
control group will not be allowed to receive music therapy outside the study.
Table 1 Benefits of music therapy for the neurodegenerative diseases
Benefits Reference Population
Improving and regulating emotional wellbeing 13, 31 Dementia, Huntington
Increasing social response 13, 31 Dementia, Huntington
Decreasing agitation 13 Dementia
Recalling life experiences 14,15, 31 Dementia, Huntington
(re)establishing contact 14,15, 31 Dementia, Huntington
Improving communication skills 11, 12, 16, 31 Dementia, Parkinson, Huntington, 
multiple disabilities
Reducing behavior and psychological symptoms 17, 18, 19, 20, 31 Dementia
Improving gait 9 Parkinson
There is evidence that music therapy influences emotional well-being positively and that par-
ticipation in music therapy increases social response in people with dementia [13]. It can 
decrease agitation and has a positive effect on enhancing communication and emotional 
well-being. Music therapy enables the recall of life experiences and the experience of pleas-
ant emotions. Through music, contact can be established, especially as language deteriorates 
during the later stage of the dementing process [14,15]. 
In a comprehensive literature search, Lee and McFerran [16] conclude that the non-verbal 
communication skills in individuals with profound and multiple disabilities improve as a result 
of song-choice during music therapy sessions. The results of their study support the belief that, 
through music therapy, the ability to express oneself will improve, contributing to improve-
ment in the quality of life.
Furthermore, in a literature review, Patel et al [17] demonstrate the effectiveness of MT in 
reducing behavioral and psychological symptoms of dementia. Several other meta-analyses 
and literature reviews have concluded that music therapy decreases symptoms related to 
behavioral problems in dementia [18-20].
On the basis of the above-mentioned literature, the assumption can be made that music ther-
apy might be beneficial to patients with HD. Although knowledge on the use and efficacy of 
music therapy in HD is limited, it has been suggested that it can improve the communication 
skills of people with HD [21]. By improving the expressive and communication skills through 
music therapy (which will be assessed by the BOSH) we hypothesize that behavioral problems 
(assessed by the BOSH and the PBA-s) will decrease, leading to an overall improvement of 
quality of life.




Patients will be recruited from four long-term care facilities (nursing homes) in The Nether-
lands, all specialized in HD, with one or more units exclusively for HD-patients. Recruitment 
will be primarily done by the nursing staff and the responsible physician.
Inclusion and exclusion criteria 
Eligible patients must meet the following inclusion criteria: 
- Age older than 18 years
- Clinically and genetically confirmed Huntington’s Disease (CAG ≥ 36 repeats) 
- Total Functional Capacity (TFC) ≤ 7
Exclusion criteria: 
- patients who suffer from other neurological disorders
- patients with poor comprehension of the Dutch language
- patients who have received music therapy in the past 3 months
- patients with a hearing impairment
Patients will be included irrespective of medication status and will be allowed to continue 
medication during the study. However, any change in medication should be avoided and care-
fully registered.
Informed consent
Informed consent will be obtained by the nursing staff from patients who are cognitively able 
to understand the possible risks and benefits of the study. Proxy consent will be obtained from 
next of kin, or a legal guardian, if the patient is not able to give an informed consent.
Baseline assessments
Clinical and demographic variables such as gender, age, (changes in) medication, number of 
CAG-repeats and (estimated) age at onset will be gathered for each participant. The stage 
of Huntington’s Disease will be assessed using the Total Functional Capacity (TFC) [22]. The 
TFC, part of the Unified Huntington Disease Rating Scale, consists of 13 points and contains 
5 domains: work, finances, domestic chores, activities of daily living and care requirements 
[22]. As the disease progresses, the TFC-score will drop, giving clinicians a good indication 
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Intervention group
The music therapists committed to the study are professionally trained and have been specif-
ically informed about the clinical method and its theoretical basis.
The main goal of the music therapy intervention is to enhance communication skills by way of 
encouraging and stimulating the patients in interaction. The music therapy approach applied in 
this study is focused on encouraging and engaging patients in expressive musical interaction. 
The role of the therapist is to use musical parameters and interventions to stimulate expressive 
and communicative skills. The degree of verbal reflection may vary; the therapist will, how-
ever, encourage the participants to express themselves. The therapeutic process is based on 
the mutual construction of meaning of emerging thoughts, images, emotional content and 
expressive qualities that often originate from the musical experience [10]. 
A treatment guide specifies the procedures. It outlines the setting, goals and basic principles 
of the intervention; Table 1 (the benefits of music therapy for neurodegenerative diseases) is 
used as guideline. The available music therapy techniques to target the set goals are derived 
from the protocol “music therapy for Huntington’s patients on improving and stimulating com-
munication and self-expression” [25]. However, the guidelines are to be administered flexibly 
according to the patient’s state of mind and his needs at that very moment. The clinical exper-
tise of the therapist will be the guide, providing the therapist with enough “space” for flexible 
adaptation within the treatment guide. Also, the patients music preference, especially because 
most of the treatment involves receptive music therapy, is very important. This is the reason 
why the protocol allows and encourages the music therapist to adjust their treatment by way 
of “tailor made” sessions, providing each of the participants with his or her music preference.
The process used in each session is standard while the content is flexible. The intervention will 
be provided at the same time of the same day of the week by a formally trained, experienced 
music therapist. The sessions will take place once weekly with a total of 16 sessions, lasting 
45 minutes. They will be standardized without limiting the music therapists in their interac-
tions. The intervention itself, however, will be (partly) applied according to a protocol. Each 
session starts with the same welcome song/musical piece and ends with the same farewell 
song/musical piece. In doing so, the participants become familiar with the start and the end 
of each session. In between these two songs/musical pieces, the music therapist adjusts the 
level of each intervention to individual capacities. After the welcome song, the music therapy 
sessions may be varied: the music experiences can range from listening to music to playing or 
singing songs to free improvisation. therapist has the freedom to determine what works best 
in the mid/advanced stage, and so impaired in his functional capacities that assistance with 
self-care is needed [22]. Most of the patients that reside in the four long term care facilities 
that participate in the study have a TFC-score of 7 or lower. To ensure a homogeneous group, 
patients with a TFC score of > 7 will be excluded from participating in the research The TFC will 
be administered by the elderly care physician who is responsible for the patient.
The Mini Mental State Examination (MMSE) will be used to assess the cognitive function of 
the patients at baseline. A score of 23 or lower out of 30 indicates cognitive impairment [23]. 
The MMSE will be administered by the psychologist or the psychology assistant.
Randomisation
In order to minimize the impact of any between-center differences on the trial results, the par-
ticipating centers will be stratified in the randomization process. Participants will be randomly 
assigned to either control or experimental group with a 1:1 allocation . To generate the random 
allocation sequence we use the method of center-stratified, block-permuted randomization 
[24]. The block size will vary. To diminish the chance of predictability, the date of signing the 
informed consent will determine the sequence in which the patients will be randomized. Not 
until all baseline measurements have been completed, the randomization code will be released 
to ensure allocation concealment.
Randomization will be conducted without any influence of the principal investigators, raters 
or therapists.
Intervention
All participants (in both the experimental (intervention) group and the control group) will 
continue to receive treatment as usual. The intervention group will receive music therapy 
(MT-group). The control group will receive recreational therapy. The number of sessions (16) 
is equal in both groups, as are the day of the week and the time of the day at which the ses-
sions will take place. Patients in both groups will participate in group interventions with three 
to five participants.
It must be noted that each of the four participating facilities have a different music therapist 
and recreational therapist attached to the research. However, all participating therapist have 
been instructed thoroughly to follow the same protocol. The reports that each therapist will 
fill out after each session will be used to monitor if they have followed the instructions.
See also “compliance with treatment”.
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All participants are allowed to leave the session at all times.
The music therapy and the recreational therapy will be provided in separate rooms, away 
from the ward. Participants will be taken to the music therapy room or the activity room by 
the nursing staff. The music therapist and the recreational therapist make sure that they can 
start the moment all participants are in the room. After the session, the participants will be 
taken back to the ward by the nursing staff. The therapists will never leave a participant in the 
room unattended. 
After each session, a short report of the activities will be written by both therapists, including 
an evaluation of each patient. Since a self-report from the patient himself is not feasible, the 
reports written by the therapists will be used for evaluation purposes and treatment fidelity.
Compliance with treatment
In each participating center a monitor will be identified, to be responsible for adherence to 
study protocol (including data collection).
Furthermore, after each session, both therapists will document significant events, notable 
behaviors, and interventions applied. These reports will enable us to determine whether the 
treatment has been conducted as intended. These reports will provide insight into the patient’s 
state of mind at the time of the intervention. This information can help us explain why cer-
tain measurements might be significantly different compared to others in the same patient. 
Self-reports (the patients’ own perception) might not be feasible, due to the rapid decline of 
cognitive skills (see rationale). Furthermore, this information will also be used to evaluate the 
process of the study.
Outcome measures
The primary outcome measure, communication skills, will be assessed by the social-cognitive 
domain of the Behaviour Observation Scale Huntington (BOSH) [26]. The secondary outcome 
measure, behavior, will be assessed by both the Problem Behaviours Assessment-short version 
[27, 28] and the third domain of the BOSH (mental rigidity and aggression).
The BOSH contains 32 items in 3 subscales: 1) activities of daily living (ADL) (5 items), 2) 
social-cognitive functioning (15 items), and 3) mental rigidity and aggression (12 items). Each 
item is assessed on a 4-point scale. The scores from the first subscale (ADL) range from 1 
(self-supporting) to 4 (nursing required). The sum score from the first scale may range from 
at that very moment for that specific patient. The participants will listen to music selected, 
sung or played by the therapist. Active participation in music activities by singing or playing a 
musical instrument will be stimulated as much as possible. The music will be selected by the 
music therapist to incite expressive and communication skills and to reduce agitation, based 
on musical parameters, such as rhythm, melody, harmony, dynamics, timbre. After each song/
musical intervention, the therapist will encourage and stimulate the participants to reflect 
verbally on the music [25]. 
Besides the music therapy intervention during the whole study, participants are not allowed 
to receive additional individual music therapy. 
All participants are allowed to leave the session at all times. 
Control group
All activities will be provided by professionally trained recreational therapists who have been 
specifically informed about the study.
In the control group, recreational day activities will be offered under exactly the same circum-
stances as the music therapy sessions: a total of 16 weekly sessions, each lasting 45 minutes, 
every week at exactly the same time as the music therapy intervention. As in the intervention 
group, a treatment guide specifies the treatment procedures for the control group. In this 
guide, the setting and general goals are outlined. The main goal of the recreational activities 
is to enhance communication skills by way of encouraging and stimulating the patients in 
interaction.. 
The activities vary from reading the newspaper, cooking, arts-and-crafts/handwork or puzzles/
games. Musical activities, such as singing along or watching a music-video are not allowed, nor 
will background-music be played. The recreational therapist is well instructed about and fully 
aware of these restrictions. Besides that, during the whole study, participants from the control 
group are not allowed to receive music therapy. Both the physician who is responsible for the 
referrals and the music therapists are fully aware of this limitation. Participation in regular 
musical activities however (such as watching a music video or attending a music-performance 
which takes place on the ward occasionally) is allowed. These activities are not considered 
to be music therapy and are open to all patients that reside in the institution, regardless of 
participation in the study. Also, listening to music in the privacy of their own room is allowed 
for all participants.
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of a knowledgeable informant (primary caregiver). 
After consulting a member of the PBA-workgroup we decided to adjust the 4-week retro-
spective view of the PBA-s to 1 week, due to the short time-frame in which it is administered 
(every 8 weeks). 
Sample size
The minimal clinically important change or difference (MCIC/MCID) in the scale serves as 
important input for the sample size calculations. Unfortunately, data about these scale-char-
acteristics are unavailable. We anticipate that the population in the present study will differ 
little from the population previously used in the study by Timman et al. [26] from which we 
derived data on means and standard deviations for the subscales of the BOSH. If we assume 
that the values in the control group will change little over the course of the study, whereas 
those in the experimental group will improve by 25%, and if we further assume an α of 0.05 
and a β of 0.20, then the following sample size would be required: 
- ADL: original mean ± SD = 2.25 ± 0.88; improvement of 25% will result in a mean of 1.69 
and if we conservatively estimate a reduction in SD to 0.75, we would require an N of 30 
per group for the ADL subscale (for an effect size of 0.55 (moderate));
- Social-Cognitive: original mean ± SD = 2.10 ± 0.79; improvement of 25% will result in a 
mean of 1.58 and if we conservatively estimate a reduction in SD to 0.75, we would also 
require an N of 30 per group for this subscale (for an effect size of 0.52 (moderate)). 
Data management and confidentiality
Participant files will be stored in locked cabinets with limited access. Participating centers will 
only have access to their own center’s data. Data will be entered into SPSS by an independent 
research assistant. After the trial the principal investigators and the statistician will have access 
to the data set. 
Statistical analysis
The primary outcome measures of this study are the differences in total and subscale-scores 
of the ADL and Social-Cognitive subscales of the BOSH and the PBA-s between groups (control 
versus MT) when baseline differences are taken into account. 
Results will be analyzed on an intention-to-treat basis.
A mixed model analysis with repeated measures will be used to analyze the differential effects 
5 to 20. The scores from the second subscale (social-cognitive functioning) range from 1 
(unaffected) to 4 (contact no longer possible); the sum score may range from 15 to 60. Finally, 
the scores from the third subscale (mental rigidity and aggression) range from 1 (never) to 4 
(always); the sum score may range from 12 to 48. Intra- and interrater reliabilities are respec-
tively 0.83 and 0.95 [26]. 
Assessment of the BOSH will take place within a week before the first intervention (baseline 
assessment), and will be repeated within a week after the 8th and again within a week after 
the 16th intervention. 12 weeks after the last intervention, the BOSH will be repeated. 
The BOSH takes 15 minutes and will be administered by nursing staff in charge of the daily 
care of the patients. Blinding the BOSH-assessors might not be feasible as the nursing staff will 
have to transport the patients to and from the therapy-rooms. Also in daily life, the chance 
of the patient divulging his or her allocation towards the nursing staff is big. However, in the 
process-evaluation following the study all the assessors will be asked whether they were aware 
of the allocation of the patients.
Since the BOSH is a commonly known assessment scale in the participating HD nursing homes 
in The Netherlands, no formal training will be carried out prior to the start of the study unless 
the particular nursing home has no experience with the BOSH.
Behavioral problems will be assessed with the Problem Behaviours Assessment-short (PBA-s) 
version [27, 28]. This is a 5-point rating scale, using the scores 0 (absent) to 4 (severe). The 
PBA-s is a 11-item semi-structured interview and assesses behavioural problems in the 4 weeks 
prior to the interview. The sum score may range from 0 to 40. In addition, there is a subscale 
for severity and one for frequency. The PBA-s is a validated and reliable measurement-tool: 
the interrater reliability is 0.74 for severity and 0.76 for frequency scores (mean kappa), and 
0.94 for severity and 0.92 for frequency scores (weighted kappa) [29] . The respondents of 
this face to face semi-structured interview are the patient and a knowledgeable informant 
(spouse or caregiver) together.
Assessment of the PBA-s will take place following the same time-schedule as the BOSH-as-
sessments. The PBA-s will be scored by independent, formerly trained assessors who will be 
blinded to group allocation of the patients. After the last assessment, the assessor will be 
asked whether or not he inadvertently found out about the patient’s allocation in order to 
verify the success of the blinding. Where possible, subjects are interviewed in the presence 
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session lasting 60 minutes, to be sufficient for detectable developments [13, 14]. 
The decision to apply the BOSH as the primary outcome measures instead of a QoL-scale 
requires some clarification; in our opinion, no validated QoL-scale (generic nor disease-spe-
cific) is sufficiently sensitive to be used in the very late stage of the disease. 
The BOSH was developed to provide an observational instrument for monitoring the behavi-
oural aspects of the patient in later stages. Expressive and communicative skills are specifically 
measured within the social-cognitive functioning-subscale. In combination with its 2 other 
subscales (ADL and mental rigidity), we believe that the scale is so broad that it covers most of 
the QoL-domains. In the present study, we are planning to analyze the total score of the BOSH.
Conclusion
This article outlines the study protocol of a randomized controlled trial providing insight into 
the effects of a structured group music therapy intervention for patients with Huntington’s 
disease. More specifically, the effects of music therapy on improving quality of life through 
specifically targeting the expressive and communicative skills, in comparison with an active 
control intervention, will be tested. 
Conclusions that will emerge from this study are expected to contribute to evidence-based 
treatment for Huntington’s Disease patients who experience deterioration of expressive and 
communicative skills, leading to a reduction in behaviour problems, and resulting in an overall 
improvement in quality of life.
List of abbreviations
BOSH: Behavioural Observation Scale for Huntington
HD: Huntington’s Disease
LTCF: Long Term Care Facility
PBA-s: Problem Behaviours Assessment-short version
QoL: Quality of Life
of music therapy versus recreational activities on the four GOSH and PBA-s scores (week 0, 
week 8 and week 16, and a follow-up score in week 28). The assessment number, ranging from 
one to four, will be used as the time variable of the repeated measures. 
As stratified randomization often leads to correlation between treatment arms, it is necessary 
to adjust for the stratification factors in the analysis to obtain correct confidence intervals and 
p-values. By doing so, we maintain the type I error rate at its nominal level (usually set at 5%), 
and avoid a reduction in power [30].
Discussion 
Music therapy is a promising non-pharmacological intervention. Through stimulation of the 
expressive and communicative skills, it is hypothesized that this therapy will result in improving 
activities of daily life and social-cognitive functioning as well as reducing behavioral problems, 
thus leading to an improvement in the quality of life. 
In general, music therapy can be offered either individually or in group sessions, with other 
patients or with family members. The sessions can be “tailor-made” for the patient and his 
needs.
In this study, patients in both the intervention- and the control group will participate in group 
interventions with three to five participants. The decision to choose group-interventions 
rather than individual interventions is based on the assumption that the interaction between 
group-members will stimulate communication [31]. In this article, Magee concludes that music 
therapy in groups is recommended in the middle and the advanced stages of HD. Group 
sessions allow the patient the time needed for delayed responses, allowing natural “time 
out” from responses which require attention or concentration. The number of participants in 
each group has to be determined carefully. In a systematic literature review, Ing-Randolph et 
al [32] suggest that group size matters with music interventions addressing certain stages of 
dementia-associated anxiety. Although Yalom [33] states that a group consisting of fewer than 
five members results in a decrease in member interaction, this is not the case when working 
with HD-patients where smaller groups are preferable [31]. 
Based on earlier RCTs and a meta-analysis of the dose-effect relationship of music therapy in 
different settings and populations, we expect a treatment duration of 16 weekly sessions, each 
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Music therapy may have beneficial effects on improving communication and expressive skills 
in patients with Huntington’s disease (HD). Most studies are, however, small observational 
studies and methodologically limited. Therefore we conducted a multi-center randomized 
controlled trial. 
Objective
To determine the efficacy of music therapy in comparison with recreational therapy in improv-
ing quality of life of patients with advanced Huntington’s disease by means of improving 
communication.
Method
Sixty-three HD-patients with a Total Functional Capacity (TFC) score of ≤ 7, admitted to four 
long-term care facilities in The Netherlands, were randomized to receive either group music 
therapy or group recreational therapy in 16 weekly sessions. They were assessed at baseline, 
after 8, 16 and 28 weeks using the Behaviour Observation Scale for Huntington (BOSH) and the 
Problem Behaviours Assessment-short version (PBA-s). A linear mixed model with repeated 
measures was used to compare the scores between the two groups. 
Results
Group music therapy offered once weekly for 16 weeks to patients with Huntington’s disease 
had no additional beneficial effect on communication or behavior compared to group recre-
ational therapy.
Conclusion
This was the first study to assess the effect of group music therapy on HD patients in the 
advanced stages of the disease. The beneficial effects of music therapy, recorded in many, 
mainly qualitative case reports and studies, could not be confirmed with the design (i.e. group 
therapy vs individual therapy) and outcome measures that have been used in the present 
study. A comprehensive process-evaluation alongside the present effect evaluation is there-
fore performed. 
Introduction
Huntington’s disease (HD) is an autosomal dominant inherited, progressive, neurodegenera-
tive disorder, characterized by a triad of motor, cognitive and psychiatric signs and symptoms. 
[1,2]. 
These characteristics often result in loss of expressive and communicative skills, especially in 
the advanced stage of the disease, frequently giving rise to behavioral problems such as anxi-
ety, irritability and apathy. The gradual deterioration in communication skills, in combination 
with the behavioral problems in patients with HD, contributes to a decrease of functional 
health and a progressive inability to participate in various life situations, leading to loss of 
quality of life [3].
Despite the increase in number of therapeutic trials over the last 20 years, there is as yet no 
cure for HD, nor can its progress be reversed or slowed down. The emphasis of all forms of 
treatments is, therefore, to improve quality of life [2]. One of these non-pharmaceutical treat-
ments offered to patients with HD in long-term care facilities is music therapy [4]. 
The American Music Therapy Association (AMTA) defines music therapy as follows: 
“Music therapy is the clinical and evidence-based use of music interventions to accomplish 
individualized goals within a therapeutic relationship by a credentialed professional who has 
completed an approved music therapy program” [5].
Music therapy uses music experiences and patient-therapist relationships in order to effect 
therapeutic change [6]. Music therapists are part of the multidisciplinary team and participate 
in interdisciplinary treatment planning, ongoing evaluation, and follow-up [5].They assess 
emotional well-being, physical health, social functioning, communication abilities, and cogni-
tive skills through musical responses. Music therapists design music sessions for individuals 
and groups based on the client’s needs, using music improvisation, receptive music listening, 
song writing, lyric discussion, music and imagery, music performance, and learning through 
music [6]. 
Specific literature about MT in HD is scarce. In a comprehensive systematic literature review, 
Van Bruggen & Roos conclude that precise music therapy aims and methods in relation to the 
stage of the disease are not well determined, and therefore there is a need for a systematic 
study to determine the effects of music therapy in HD [7]. 
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Over the past decades, music therapy (MT) has been developed for patients with other neu-
rodegenerative diseases [8,9]. There is evidence that music therapy influences emotional 
well-being positively and that participation in music therapy increases social responses in 
persons with dementia, thus providing additional means of communication and enabling the 
patient to express his or her needs and emotions [10, 11]. Through music, contact can be 
established, especially as language deteriorates during the later stages of the dementia pro-
cess [12]. The patient can be stimulated to recall life experiences through music. In the music 
therapy session this can be used as a catharsis to experience emotions. Furthermore, MT can 
reduce behavioral and psychological symptoms of dementia [4, 14, 15, 16]. 
Finally, enhancing the ability for self-expression, contributing to improvement of the quality of 
life, has been reported by Lee and McFerran who in a multiple case study describe five females 
with profound and multiple disabilities using song-choices in music therapy [13]. 
 
Based on the aforementioned benefits, the assumption can be made that music therapy is 
potentially a valuable non-pharmacological intervention to improve communication skills and 
thus possibly reduce behavioral problems, leading to a better quality of life (QoL) overall, in 
people with HD.
The aim of the present study is to evaluate the effect of group music therapy, compared to 
group recreational therapy (RT), on communicative and expressive skills in relation to behavior 
changes. 
The research questions are
1. Does MT improve expressive and communicative skills in people with HD?
2. Does MT reduce behavioral problems in patients with HD? 
Methods
An extensive description of the protocol has been published elsewhere [17]. 
Participants 
Sixty-three patients with a clinically and genetically confirmed diagnosis of HD, 18 years and 
older, with a maximum TFC-score of 7 [18] were included. They were recruited from four 
different long- term care facilities in The Netherlands which specialize in HD-care. Patients 
with poor comprehension of the Dutch language or with hearing-impairments were excluded. 
Patients with other neurological disorders and patients who had received music therapy within 
the three months prior to the study were also excluded. Patients were allowed to continue 
their regular medication during the study, and any change in use was carefully registered. All 
patients and/or their legal representatives gave informed consent. The study was approved by 
the medical ethical committee of the Leiden University Medical Center (LUMC) in The Nether-
lands (registration # P14.038) and all local committees in the four nursing homes. 
Patients were allocated to either the intervention group (music therapy) or the control group 
(recreational therapy). Recreational therapy was chosen over “no intervention/treatment as 
usual” because being a complex, multi-faceted intervention as is music therapy, recreational 
therapy to us seemed to be the most appropriate control intervention to make the two groups 
as homogeneous in personal attention and thus as comparable as possible.
Patients in both groups participated in group interventions with three to five participants. 
The decision to use group therapy instead of individual therapy was based on Magee [19, 20] 
who recommends music therapy group intervention in the mid- and late stage of the disease.
Randomization
Participants were randomized using stratified permuted block randomization with a 1:1 ratio 
of music therapy to recreational therapy. For details see the flowchart in fig.1. 
The participants were stratified per center. Two independent persons per center conducted 
the randomization. The block-size varied from three to five persons, depending on the total 
number of participants in the center. The date of signing the informed consent was used to 
determine the sequence in which the participants were randomized. The decoded allocation 
was revealed after all baseline measurements had been taken. After randomization, the par-
ticipants were considered part of the study, regardless of whether they decided to leave the 
study prematurely (intention-to-treat principle). 
Data collection
All measurements were collected in patients’ files and stored in locked cabinets. Data were 
entered into SPSS version 22 by an independent research assistant. 























































The assessors conducting the measurements were kept unaware of the patient’s allocation, 
as was the principal investigator and the statistician. The allocation was not revealed until 
all analyses had been completed and conclusions drawn. Blinding the nursing staff, who was 
responsible for some of the measurements, was not always feasible as some of the nurses 
were also responsible for transporting the patients to and from the therapy rooms, as the 
number of available nurses on the ward was limited. Furthermore, blinding of the principal 
researcher and the statistician, who were responsible for the statistical analysis, was guaran-
teed: all data were coded, ensuring both were unaware of the allocation, the institute, the 
gender, the age and the use of medication of each participant. The dataset was not decoded, 
nor were the allocations revealed until the analysis had been completed.
Baseline assessments 
Clinical and demographic variables (gender, age, use of psychotropic medication) were assessed 
at baseline (see table 1). The Mini Mental State Examination (MMSE) [21] was assessed at 
baseline to determine whether the cognitive functioning of the patients in the intervention 
group was different than those of the patients in the control group after randomization. Assess-
ment of the MMSE was carried out by a psychologist or an assistant psychologist at the start 
and at the end of the study. Due to the severe cognitive state of the participants, the MMSE 
could not be assessed for 22 participants in the first assessment and for 26 participants in the 
second assessment. The missing scores were set to zero. 
Outcome parameters
For a comprehensive description of the used items of the two measurement tools see appen-
dix 1.
The primary outcome measure of the study was the social-cognitive functioning subscale of 
the Behaviour Observation Scale Huntington (BOSH) [22]. This scale consists of 15 items which 
were expected to detect changes in communicative and expressive skills. We choose this 
subscale as the primary outcome measure because it was hypothesized that through stimu-
lation of these skills, activities of daily life and social-cognitive functioning will improve. As a 
result, behavioral problems (being the secondary outcome measures, see below) will reduce, 
overall leading to an improvement in the quality of life [17]. The scores of this subscale range 
from 1 (unaffected) to 4 (contact no longer possible); the sum score may range from 15 to 
60. The BOSH-assessments were administered by previously trained nursing staff in charge 
of the daily care of the patients. Assessment of the BOSH took place at a random time point, 
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one week before the first intervention (baseline assessment), and was repeated after the 8th 
and the 16th intervention. Finally, the last BOSH-assessment took place 12 weeks after the last 
intervention (week 28).
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The secondary outcome measures, behavioral problems, were assessed by the third subscale 
of the BOSH [18] and the Problem Behaviours Assessment-short version (PBA-s) [23, 24]. 
This subscale of the BOSH, the mental rigidity and aggression subscale, consists of 12 behav-
ior-related items; the scores range from 1 (never) to 4 (always); the sum score can range from 
12 to 48. 
The PBA-s consists of 11 semi-structured interview items and assesses behavioral problems in 
the 4 weeks prior to the interview. After consulting the PBA-workgroup, however, we adjusted 
the retrospective 4 weeks to 1 week, due to the short time-frame in which the PBA-s had to be 
administered. The PBA-s is a 5-point rating scale with subscales for severity and for frequency. 
The severity subscales uses the scores 0 (not at all) to 4 (severe/intolerable). The frequency 
subscale scores from 0 (absent) to 4 (all day, every day). Severity and frequency scores are 
multiplied to produce an overall PBA-score for each symptom. The PBA-s was scored by inde-
pendent, trained psychologists who were blinded to group allocation of the patients.
The timeline of the assessment of the primary and secondary outcome measures is depicted in 
figure 1.
Intervention
The study was conducted between October 2014 and May 2016. Over a period of 16 weeks, 
participants received either music therapy or recreational therapy. All participants received 
their usual treatment while participating in the study and were not allowed to receive addi-
tional individual music therapy. Participants were free to leave the session or discontinue 
participation at any time. Each group consisted of three to five participants. The four partici-
pating centers had their own professionally trained music therapist and recreational therapist. 
They were all fully instructed to adhere to the study-protocol.  
In the music therapy group, each of the 16 music therapy interventions lasted 60 minutes 
and was provided weekly. The music therapy approach focused on encouraging and engaging 
participants in expressive musical interaction [6]. The intervention was partly described in 
a protocol, a treatment guide in which the setting, goals and basic principles of the inter-
vention were outlined, and the procedure itemized. The music therapy techniques aimed at 
achieving the goals were derived from the protocol “music therapy for Huntington’s patients 
on improving and stimulating communication and self-expression” [25]. The music therapists 
were encouraged to be flexible while using the guidelines, allowing the “state-of-mind” of 
the participant, in combination with the therapist’s own clinical experience, to be the guide. 
While the sessions were partly standardized without limiting the music therapists in their 
interactions, the intervention itself was to be applied according to the protocol: each session 
started with the same welcome song and ended with the same farewell song. Between these 
two songs, the music therapist was allowed to adjust the level of each intervention according 
to individual capacities. The music experiences could range from listening to music to playing 
or singing songs to free improvisation. 
In the control group, recreational activities were offered under exactly the same circumstances 
as the afore-mentioned music therapy sessions. As in the intervention group, a treatment guide 
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described the procedure for the control group. The main goal of the recreational activities was 
to enhance communication skills by way of encouraging and stimulating the patients to inter-
act. The activities could vary from reading the newspaper, cooking, arts-and-crafts/handwork 
or puzzles/games. Musical activities, such as singing along or watching a music-video, were not 
allowed, nor was background music to be played during the activities. Participation in musical 
activities in the facility (such as attending an in-house music performance) was allowed. These 
activities are not considered to be music therapy and are open to all patients residing in the 
institution, regardless of participation in the study. Also, listening to music in the privacy of 
their own room was allowed for all participants throughout the study.
Statistical analysis 
Sample size was determined based on the ICC of the primary outcome measurement(BOSH )
[18]. We assumed that the values in the control group would not change very much over the 
course of the study, whereas those in the experimental group would improve by 25%. We 
further assumed an α of 0.05 and a ß of 0.20. Based on these assumptions, we came to the 
following sample size calculation:
- Social-cognitive original mean (SD) = 2.10 (1.58) and if we conservatively estimate a reduc-
tion in SD to 0.75, we would require an N of 30 per group for this subscale (for an effect 
size of 0.52 (moderate)).
For the data-analysis, we followed the same statistical procedure for all three (primary and 
secondary) outcome measures:
First we calculated the mean sum scores of the scale (see figure 2). The sum score of the 
baseline-values was then used as a covariate in the subsequent mixed model analysis as these 
baseline scores appeared to be different between the MT-group and the RT-group.
A linear mixed model with repeated measures was used to compare the four BOSH and PBA-s-
scores of the experimental and the control group, fitting condition (MT or RT) and time variable 
(the assessment number) as fixed effects in the model. 
As stratified randomization can lead to correlation between treatment arms, we adjusted for 
the stratification factor (i.e. the institution) in the analysis to obtain correct confidence inter-
vals and p-values by fitting the institution code as a factor in our linear mixed model. 
All data were gathered and stored in locked cabinets in the four different participating centers 


















Fig. 2a Mean sum scores (range 15-60) of the social/cognitive domain of the BOSH for both 


















Fig. 2b Mean sum scores (range 12-48) of the mental rigidity/aggression- domain of the 
BOSH for both conditions at each of the four time-points.
 




















Fig. 2c Mean sum scores (range 0-176) of the severity/frequency scale of the PBAs for both 
conditions at each of the four time-points.
Results
A total of 187 residents from four different long-term care facilities were eligible to participate 
in the study. Of these, 124 residents were not included for various reasons: not meeting the 
inclusion criteria, refusing consent, medical advice or poor compliance. The remaining 63 
participants were randomized to either music therapy (n=32) or recreational therapy (n=31). 
Of these, a total of 9 participants (5 from the MT group and 4 from the RT group) were lost 
to follow-up, due to death (n= 4), moving to another care-facility (n=1), or lack of motivation 
(n=4). This resulted in 54 participants remaining (27 randomized to MT and 27 to RT). See the 
flowchart in figure 1.
At baseline, the mean TFC-score of the MT-group (1.00) tended to be somewhat lower than 
that of the RT-group (1.90), indicating a lower functioning level of participants in the MT-group. 
However, this difference was not significant (p = .03). For all other characteristics (gender, age) 
the two groups did not differ significantly either. 
For both conditions at each of the four time-points, the unadjusted mean sum scores of the 
social/cognitive subscale of the BOSH are shown in figure 2a, of the mental/rigidity/aggression 
subscale of the BOSH in figure 2b, and of the severity/frequency scale of the PBAs in figure 2c. 
Note that a lower score means improvement for all three outcome measures.
Linear mixed models analyses showed that 
- the difference between conditions at the three post-baseline time points, after correc-
tion for the difference in baseline values, can assumed to be constant as there was no 
effect-modification (interaction) of these differences by time (see figure 2); 
- the difference between the estimated means of the scores of the social/cognitive subscale 
of the BOSH between the two conditions (2.88) at the three post-baseline time points 
is significant at the .05 level (p = .042), with a beneficial effect for the control condition; 
- the difference between the estimated means of the scores of the mental rigidity/aggres-
sion subscale of the BOSH between the two conditions (4.60) at the three post-baseline 
time points is not significant at the .05 level (p = .125);
- the difference between the estimated means of the scores of the severity/frequency 
scales of the PBA-s between the two conditions (-1.39) is not significant at the .05 level 
(p = .630).
See table 2.
When institute was added as a fixed effect in our model, there was no interaction effect 
between institute and condition, i.e. the difference between the means of the sum-scores of 
the two conditions did not depend on the institute for any of the three domains. 
Table 2. Estimate of the fixed effects of the primary and secondary outcome measures
Estimate Significance 95% Confidence interval
Upper bound Lower bound
SocCog1 
(Primary Outcome)
2.88 .042 .108 5.65
MentRigAggr2 
(Secondary Outcome)
4.60 .125 -1.32 10.52
PBAsSevFreq3 
(Secondary Outcome)
-1.39 .630 -7.16 4.38
1 social/cognitive subscale of the Behavioural Observation Scale Huntington  
2 mental rigidity/aggression subscale of the Behavioural Observation Scale Huntington  
3 severity/frequency scale of the Problem Behaviours Assessment-short version 
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Discussion
In the present study we have looked for answers to the following three research questions:
1. Does MT improve expressive and communicative skills in people with HD?
2. Does MT reduce behavioral problems in patients with HD? 
Music therapy offered to patients with Huntington’s disease once weekly for a period of 16 
weeks had no additional beneficial effect on improving expressive and communicative skills 
or on reducing behavioral problems when compared to recreational therapy. A slight clinical 
effect was found in the primary outcome measure (the social and cognitive subscale of the 
BOSH) in favor of recreational therapy. In our opinion, the clinical relevance of this outcome 
is negligible as the difference in outcome between the two conditions was very small. No 
significant effect could be found for the two secondary outcome measurements (the mental 
rigidity/aggression subscale of the BOSH and the severity/frequency scale of the PBA-s) in 
favor of MT or RT.
There seems to be a discrepancy between subjective (qualitative) positive evaluations that 
have been published and the objective (quantitative) outcome measures that are reported in 
this study. This is also highlighted in a comprehensive literature review [7]. Possible explana-
tions of this apparent discrepancy are that this study is the first randomized controlled trial 
applying music therapy for patients in the advanced stage of Huntington’s disease, involving 
a relatively large number of participants. 
The strength of the study is three-fold: 
First: The design: randomization took place separately in each participating facility. Anticipating 
the possibility of unbalanced and missing data, we decided to use a linear mixed model to 
analyze the results. 
Second: The fact that we used an active condition in the control group, providing similar 
degrees of attention and group contact in both groups. Most studies to date have used “treat-
ment as usual” as the control condition. 
Third: The fact that on the one hand, the clinical method was clearly defined: both interven-
tions were (partly) protocolled, guiding all therapists to conduct a similar and thus comparable 
procedure during the sessions. On the other hand, the therapists had the freedom to elaborate 
during each session as long as each of them aimed for the same goals. 
It should also be mentioned that conducting an RCT with vulnerable late stage HD-patients is 
very challenging. The burden of participating in such studies is heavy, especially for the patients 
in the more advanced stages of the disease as in our study, who are more likely to drop out 
before completing the trial [1]. 
Several limitations of the present study may be the cause of the above-mentioned discrepancy 
between quantitative and qualitative evidence:
A. The vulnerability of the target population in relation to compliance with treatment.
Considering the low scores on both the MMSE and the TFC, the severity of the cognitive 
impairments at this stage of the disease is obvious. In the literature review [7], the HD-patients 
included in the studies were in the early or mid-stage of the disease, while in the present study, 
all participating patients were in the advanced stage. 
Although participants were allocated to the groups by randomization, the scores of those in the 
music therapy group were somewhat lower in both the MMSE and the TFC, indicating a more 
severe functional and cognitive state in the MT-group. Adjustment for TFC-scores however did 
not provide different results, indicating that the functional difference was not a confounder.
The factors mentioned here might also explain the large number of sessions missed and hence 
the missing data (see table 1). The strength, however, of performing a mixed model technique 
is that it is less sensitive to missing data than “classical” techniques through its restricted 
maximum likelihood estimation of effects.
B. The sensitivity of the measurement tools for the advanced stage of the target population.
The assessment tools (BOSH and PBA-s) might not have been the most eligible, as they might 
not be sensitive enough to detect marginal clinical effects in the later stages of the disease. 
However, the tools that were available at the time of designing the study were expected to be 
not eligible to use in advanced stage patients (the target population of the presented study). 
The choice for the BOSH and the PBA-s was based on the expectation that the items of (the 
subscales of) these tools would detect changes in communication and expressiveness, as well 
as in behavior, see appendix 1. A good alternative for future studies might be the UHDRS-FAP 
(Unified Huntington’s Disease rating Scale - For Advanced Patients) [26]. This is the only scale 
that detects decline in patients with a TFC-score ≤ 1. The UHDRS-FAP was developed in 2013 
and appears to be more sensitive to change than the original UHDRS for cognitive and motor 
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domains. Also, a pilot validation study of the Music therapy Assessment Tool for Advanced 
Huntington’s Disease (MATA-HD) has just finished in the UK [27]: preliminary data indicate that 
the MATA-HD is a promising tool for measuring patient’s responses to music therapy inter-
ventions across psychological, physical, social and communication domains of functioning in 
patients with advanced HD. Neither tool was available yet when designing the present study. 
Furthermore, validated measurement tools that are sensitive for emotional and social cogni-
tive responses in dementia (see introduction) might be suitable to use in future studies with 
HD-patients. 
C. The short-term effect of the intervention.
It would be quite valid to raise questions about the frequency and the time-points of the 
assessments. It is possible that the short-term effect of the intervention might not have been 
detected in the present study. In a comparable study which determined the effects of music 
therapy in reducing behavioral problems in elderly people with dementia, measurements 
were taken one hour before the session, and one, two and four hours after the session [28]. 
In our opinion this was not feasible in the present study due to the severity of the participants’ 
condition. 
D. Group-intervention versus individual intervention.
Group intervention, even though the group-size was small, might not have been the best 
option. In our opinion, contrary to Magee [19,20], at this late stage of the disease, individual 
therapy might be preferable. 
Finally: when designing the study protocol we initially developed a third research question: 
‘does MT improve quality of life of patients with HD?’. We decided to omit this third question, 
as the relation between the primary and secondary outcome measures and improvement of 
the quality of life of patients with HD could not be evaluated in the present study with the 
assessment tools that were used. This third research question remains open for discussion. 
However, the lack of quantitative outcome measures supporting the beneficial effects of music 
therapy on communication and behavior in patients with HD does not implicate that music 
therapy does not have a beneficial effect on improving quality of life. When evaluating inter-
ventions that have the potential to improve quality of life, finding the best research designs 
and the best outcome measures for patients in the advanced stage of HD remains a major 
challenge. 
Conclusion
This was the first study to assess the effect of group music therapy on HD patients in the 
advanced stages of the disease. The beneficial effects of music therapy, recorded in many, 
mainly qualitative case reports and studies, could not be confirmed with the design (i.e. 
RCT, group therapy vs individual therapy) and outcome measures that have been used in the 
present study. A comprehensive process-evaluation alongside the present effect evaluation 
is therefore performed. The outcome of this process evaluation is expected in the Spring of 
2017 and will be published elsewhere. This will result in recommendations for future research 
to strengthen the (quantitative and qualitative) evidence for implementing music therapy in 
rehabilitation for persons with Huntington’s Disease. 
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APPENDIX 1:
Behavior Observation Scale Huntington (BOSH) – second subscale (social/cognitive func-
tioning)
6.  Ability to understand complex actions such as operating an electric wheelchair, a com-
municator, other electrical appliances, and so on
7.  Voice control (control of sound and volume) and articulation
8.  Intelligibility
9.  Comprehensibility through nonverbal communication
10.  Ability to understand verbal communication
11.  Ability to understand nonverbal communication
12.  Recollection of recent events important to patient (birthdays, trips, weddings)
12.  Remembering appointments
13.  Ability to occupy himself/herself, if necessary, using a diary
14.  Ability to occupy himself/herself and participate in organized activities
15.  Patient knows staff members and fellow inpatients by name
16.  Emotionalism
17.  Awareness of being ill
18.  Seeking contact and receptiveness
19.  Contact with family, friends, or fellow inpatients
20.  Showing consideration for fellow inpatients
Behavior Observation Scale Huntington (BOSH) – third subscale (mental rigidity and aggres-
sion)
21.  Degree to which verbal and physical aggression can be corrected
22.  Tendency toward verbal and physical aggression
23.  Patient tries to exceed the limits of standing agreements or house rules
24.  Patient causes problems if a fixed routine is not adhered to
25.  Patient accepts what you say
26.  Patient is open to correction
27.  Performance of specific activities is impeded because patient cannot dissociate from 
subjects or events that are not or are no longer relevant
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28.  Patient performs stereotypical, apparently aimless activities (such as walking and then 
sitting down again immediately), which take precedence over everything
29.  Choking while eating or drinking
30.  Eating and drinking
31.  Voracity and insatiability
32.  Bolting food





5. Angry or aggressive behaviour
6. Lack of initiative (apathy)
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APPENDIX 2:
Description of the procedures of the music therapy and the recreational therapy sessions
All participants (in both the experimental (intervention) group and the control group) will 
continue to receive treatment as usual. The intervention group will receive music therapy 
(MT-group). The control group will receive recreational therapy. The number of sessions (16) 
is equal in both groups, as are the day of the week and the time of the day at which the ses-
sions will take place. Patients in both groups will participate in group interventions with three 
to five participants.
Intervention group
The music therapists committed to the study are professionally trained and have been specif-
ically informed about the clinical method and its theoretical basis.
The main goal of the music therapy intervention is to enhance communication skills by way of 
encouraging and stimulating the patients in interaction. The music therapy approach applied in 
this study is focused on encouraging and engaging patients in expressive musical interaction. 
The role of the therapist is to use musical parameters and interventions to stimulate expressive 
and communicative skills. The degree of verbal reflection may vary; the therapist will, how-
ever, encourage the participants to express themselves. The therapeutic process is based on 
the mutual construction of meaning of emerging thoughts, images, emotional content and 
expressive qualities that often originate from the musical experience [10]. 
A treatment guide specifies the procedures. It outlines the setting, goals and basic principles 
of the intervention; Table 1 (the benefits of music therapy for neurodegenerative diseases) is 
used as guideline. The available music therapy techniques to target the set goals are derived 
from the protocol “music therapy for Huntington’s patients on improving and stimulating com-
munication and self-expression” [25]. However, the guidelines are to be administered flexibly 
according to the patient’s state of mind and his needs at that very moment. The clinical exper-
tise of the therapist will be the guide, providing the therapist with enough “space” for flexible 
adaptation within the treatment guide. Also, the patients music preference, especially because 
most of the treatment involves receptive music therapy, is very important. This is the reason 
why the protocol allows and encourages the music therapist to adjust their treatment by way 
of “tailor made” sessions, providing each of the participants with his or her music preference.
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The process used in each session is standard while the content is flexible. The intervention will 
be provided at the same time of the same day of the week by a formally trained, experienced 
music therapist. The sessions will take place once weekly with a total of 16 sessions, lasting 
45 minutes. They will be standardized without limiting the music therapists in their interac-
tions. The intervention itself, however, will be (partly) applied according to a protocol. Each 
session starts with the same welcome song/musical piece and ends with the same farewell 
song/musical piece. In doing so, the participants become familiar with the start and the end 
of each session. In between these two songs/musical pieces, the music therapist adjusts the 
level of each intervention to individual capacities. After the welcome song, the music therapy 
sessions may be varied: the music experiences can range from listening to music to playing or 
singing songs to free improvisation. therapist has the freedom to determine what works best 
at that very moment for that specific patient. The participants will listen to music selected, 
sung or played by the therapist. Active participation in music activities by singing or playing a 
musical instrument will be stimulated as much as possible. The music will be selected by the 
music therapist to incite expressive and communication skills and to reduce agitation, based 
on musical parameters, such as rhythm, melody, harmony, dynamics, timbre. After each song/
musical intervention, the therapist will encourage and stimulate the participants to reflect 
verbally on the music [25]. 
Besides the music therapy intervention during the whole study, participants are not allowed 
to receive additional individual music therapy. 
All participants are allowed to leave the session at all times. 
Control group
All activities will be provided by professionally trained recreational therapists who have been 
specifically informed about the study.
In the control group, recreational day activities will be offered under exactly the same circum-
stances as the music therapy sessions: a total of 16 weekly sessions, each lasting 45 minutes, 
every week at exactly the same time as the music therapy intervention. As in the intervention 
group, a treatment guide specifies the treatment procedures for the control group. In this 
guide, the setting and general goals are outlined. The main goal of the recreational activities 
is to enhance communication skills by way of encouraging and stimulating the patients in 
interaction.. 
The activities vary from reading the newspaper, cooking, arts-and-crafts/handwork or puzzles/
games. Musical activities, such as singing along or watching a music-video are not allowed, nor 
will background-music be played. The recreational therapist is well instructed about and fully 
aware of this restriction. Besides that, during the whole study, participants from the control 
group are not allowed to receive music therapy. Both the physician who is responsible for the 
referrals and the music therapists are fully aware of this limitation. Participation in in regular 
musical activities however (such as watching a music video or attending a music-performance 
which takes place on the ward occasionally) is allowed. These activities are not considered 
to be music therapy and are open to all patients that reside in the institution, regardless of 
participation in the study. Also, listening to music in the privacy of their own room is allowed 
for all participants.
All participants are allowed to leave the session at all times.
The music therapy and the recreational day activities will be provided in separate rooms, away 
from the ward. Participants will be taken to the music therapy room or the activity room by 
the nursing staff. The music therapist and the recreational therapist make sure that they can 
start the moment all participants are in the room. After the session, the participants will be 
taken back to the ward by the nursing staff. The therapists will never leave a participant in the 
room unattended. 
After each session, a short report of the activities will be written by both therapists, including 
an evaluation of each patient. Since a self-report from the patient himself is not feasible, the 
reports written by the therapists will be used for evaluation purposes and treatment fidelity.
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This article reports the process evaluation of a multi-center randomized controlled trial in which 
the effect of music therapy in Huntington’s disease (HD) was studied. The beneficial effects of 
this complex intervention, recorded in many, mainly qualitative case reports and studies, could 
not be confirmed with the design and outcome measures used in the present study. To find 
possible explanations for this discrepancy, we performed a comprehensive process-evaluation. 
Aim
To evaluate the execution of this randomized controlled trial (RCT) by collecting information 
regarding (1) the study population, (2) the intervention and (3) the outcome measures. The 
evaluation will result in recommendations for future studies regarding study population, imple-
mentation and adjustment of the intervention and appropriate study design.
Method
A mixed model of qualitative and quantitative data was used. Qualitative data were analyzed 
following the guidelines of thematic analysis within the grounded theory and naturalistic inquiry. 
Quantitative data were derived from the evaluation forms and were accounted for in the analysis. 
Results
The experience of twenty professionals was evaluated using an online survey, questionnaires, 
interviews, observation forms and field notes. The most obvious barrier was the severe cogni-
tive decline of the study population in combination with circumstances within the participating 
centers, and the assessment tools that might not have been sensitive enough for the set goals 
of the RCT. 
Conclusion
Performing a multi-center RCT studying the efficacy of music therapy with vulnerable patients in 
a long-term care facility is feasible, but challenging. No matter how complex the intervention and 
the study population, with the right study design, outcome measures and assessment tools, and 
with an unambiguous written protocol, and a continuous evaluation and monitoring through-
out the whole study, barriers can be by-passed or avoided, and facilitators can be empowered. 
Suggestions are made for future research concerning the use of alternative designs (multiple 
single subject design study) and measurement tools (Goal Attainment Scale (GAS), Music Therapy 
Assessment Tool for Advanced HD (MATA HD)). 
Introduction
This article reports the process evaluation of a randomized controlled trial (RCT) studying the 
effects of music therapy in patients with advanced stage Huntington’s disease. An extensive 
description of the protocol (methods, randomization procedure, and intervention) and the 
results of this RCT are published elsewhere [1, 2]. Below is a short summary. 
Music therapy is considered a complex intervention. These are interventions comprising multi-
ple components acting independently or interdependently, and therefore difficult to develop, 
document, evaluate and reproduce. It is increasingly recognized that especially these kinds of 
interventions should be rigorously evaluated [3]. Documenting and evaluating each process 
step in detail, exploring the execution, implementation, receipt and setting of an intervention 
will help the interpretation of outcome parameters and designing future trials [4]. 
Huntington’s disease (HD) is a progressive, neurodegenerative disease with autosomal domi-
nant inheritance, characterized by motor disturbances, cognitive decline and behavioral and 
psychological symptoms and signs. These signs result in progressive functional decline [5] 
and a gradual loss of expressive and communicative skills. This combination leads to loss of 
quality of life [6]. 
Since there is no cure, all treatment is aimed at improving quality of life. One of these non-phar-
maceutical treatments offered to patients with HD in long-term care facilities is music therapy.
Music therapy is defined as “…the clinical and evidence-based use of music interventions to 
accomplish individualized goals within a therapeutic relationship…”[7]. Through music therapy 
an additional means of communication can be provided, enabling the patient to express his 
needs and emotions [8]. Furthermore, through music, contact can be established, especially 
as language deteriorates, such as for instance during the later stages of dementia [9]. 
The use and efficacy of music therapy in patients with Huntington’s disease on a large scale has 
hardly been studied. Therefore, a multi-center single blind randomized controlled trial (RCT) 
has been conducted between October 2014 and May 2016 in four long-term care facilities 
specialized in Huntington’s disease-care in The Netherlands [2]. The main goal of the RCT was 
to study the effect of music therapy on improving expressive and communication skills and 
behavior in patients with advanced HD. Sixty-three patients were randomised using center-
stratified block-permuted randomisation. Two random groups were created. Over a period 
of 16 weeks, the experimental group was offered a weekly music therapy program according 
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to a structured protocol, and the control group participated in weekly regular recreational 
therapy. Both therapies can be seen as complex intervention, difficult to develop, document, 
evaluate, and reproduce [10,11] (see box 1). In addition, both groups received usual care. 
The primary outcome measure to assess changes in expressive and communication skills was 
the second subscale (social cognitive functioning) of the Behaviour Observation Scale Hun-
tington (BOSH) [12]. Changes in behavior were assessed by the third subscale (mental rigidity 
and aggression) of the BOSH and the Problem Behaviours Assessment-short version (PBA-s) 
[13]. The effect-evaluation showed that these outcomes did not improve in the MT group as 
compared to the control group [2].
Box 1: What makes an intervention complex [10,11]
- Number of interacting components within the experimental and control interventions
- Number and difficulty of behaviors required by those delivering or receiving the intervention
- Number of groups or organizational levels targeted by the intervention
- Number and variability of outcomes
- Degree of flexibility or tailoring of the intervention permitted
This article reports the process evaluation of the aforementioned randomized controlled trial. 
The aim of the study is to evaluate the execution of this RCT by collecting information regarding 
(1) the study population, (2) the intervention and (3) the outcome measures. The outcome 
will result in recommendations for future studies in regard to study design, study population, 
implementation and adjustment of the intervention and outcome measures.
This study design as well as the music therapy intervention can be seen as an example of a 
complex intervention [10,11] because:
- It is a multi-center trial: the trial took place in four different long term care facilities. 
- All four institutes had their own therapists, psychologists, physicians, and nursing staff 
who were involved in the trial. All professionals had to be instructed separately.
- Two different measurement tools had to be assessed by many different assessors at four 
different moments in a 28-week timeframe. All assessors had to be trained.
- The participants receiving the intervention all were diagnosed with Huntington’s disease 
in advanced stage, a disease with a wide spectrum of symptoms and signs.
- Interventions like music therapy are designed to be adapted to the specific needs of the 
patient (“tailor made”) and to local circumstances. Therefore, a high flexibility-rate was 
demanded from the music therapists.
METHOD
The method as well as the results and implications of the present process evaluation are pre-
sented using the format that is based on the following three components [10]: 
(1) The success rate of recruitment and quality of the study population;
(2) The quality of execution of the complex intervention, and; 
(3) The process of acquisition of the evaluation data. 
See for the related process measures of these three components box 2 [10].
Box 2: Process-evaluation components and related process measures of a complex inter-
vention [10]
Process Components  Process Measures
Study population  1. Recruitment and selection rate
   2. Barriers and facilitators in recruitment and selection process
   3. Follow-up: attrition rate
   4. Barriers and facilitators for follow-up
Multiple components  1. Quality of delivery of the interventional components
   2. Barriers and facilitators for delivery of interventional components
   3. Adherence to interventional components
   4. Barriers and facilitators for adherence to interventional components
   5. Experience of participants and instructors with intervention components
Evaluation data  1. Outcome measures: coverage of interventional components
   2. completeness of data collection
   3. Barriers and facilitators for data collection
Participants
Due to the vulnerability of the patients with HD in the advanced stage, we did not involve 
them in the process-evaluation: the burden of being exposed to additional questionnaires was 
an important consideration. Observation forms filled out by the therapists after each session 
were consulted to determine the patient’s compliance and experience.
We used a purposive sampling strategy to select 20 professionals who had been involved in 
the execution of the trial. In doing this, we made sure that each group of professionals and 
each of the four participating centers were equally represented. Participating professionals 
were one team per site, consisting of a site monitor, a music therapist, a recreational therapist, 
a BOSH-assessor, and a PBA-s-assessor. 
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Data collection
A mixed method of qualitative and quantitative data collection was used to analyze the 
responses obtained from:
- Online survey of monitors, assessors and nursing staff and therapists;
- Evaluation forms filled out by music therapists and recreational therapists after each 
session;
- Interviews with one of each of the monitors, assessors, nursing staff and therapists;
- Notes taken during contact with monitors and research assistant.
Online survey of monitors, assessors, nursing staff and therapists 
An online survey was sent to all 20 participating professionals. Each of the three process 
components mentioned above was assessed in the questionnaire that consisted of ten open 
questions about the study population, the quality of execution of the complex intervention, 
and the process of acquisition of the evaluation data. 
Evaluation forms filled out by music therapists and recreational therapists after each session 
Evaluation forms were filled out by the eight therapists involved in the study (four music 
therapists and four recreational therapists) after each session. These forms provided both 
qualitative and quantitative data about the treatment compliance of the patients, about dis-
turbing factors prior to or during the intervention, and were used to check what activities 
and which techniques were used during the sessions and if this matched with the protocol. 
Interviews with the monitors, assessors, nursing staff, and therapists 
In addition to the questionnaires, we used face-to-face semi-structured interviews with four 
other professionals that were involved in the execution of the study: one BOSH-assessor, one 
PBA-assessor, one music therapist and one recreational therapist. They were chosen by way 
of convenience sampling. 
The three components mentioned above (study population, complex intervention and 
data-evaluation) were the guideline during the (semi-structured) interviews. 
Notes taken during contact with monitors and research assistant
Furthermore, the four monitors of each participating center had contact with the principal 
researcher (MvBR) on a regular base throughout the whole study. This ensured the progress 
of the study, the adherence of the protocol and the data collection (i.e. random check of the 
raw scores in the data base). The frequency and the intensity of this contact differed between 
the sites. Also, the research assistant (MH) visited the four participating centers on a regular 
basis, checking the raw scores, and entering all collected data into SPSS version 22. Site notes 
of all her visits, phases of data collection and data preparation were also included in the 
present process evaluation. 
Procedure Data collection
Guidelines of two methods were followed: the naturalistic inquiry [14] and the thematic ana-
lysis in accordance with the grounded theory of Glaser & Strauss [15]. The first is a method 
that emphasizes the trustworthiness of the study, while the second is an analytical approach 
used most frequently in grounded theory studies whereby theoretical insights are generated 
from qualitative data (inductive process) [16]. 
Trustworthiness
To ensure credibility and trustworthiness we used the following procedures:
a) Triangulation
We ensured methodological and data triangulation by using different methods of data col-
lection (online survey, questionnaires, observation forms, interviews and site notes).
b) Confirmability
During the analysis, the research assistant (MH) examined the analysis process and records 
for accuracy (confirmability). The interpretations of the data and the preliminary results were 
presented and discussed with the principal researchers’ supervisors (AV, WA, RR) Their objec-
tive feedback was used to finalize the conclusions of the study.
Analysis
The analysis was conducted by the principal researcher (MvBR). The three components men-
tioned above [10] (study population, complex interventions and data-evaluation) were the 
guideline throughout the whole analysis procedure. 
The themes and concepts were derived from the data by using the open coding system: dif-
ferent categories were identified and codes that described the same themes were clustered 
or deducted (see figure 1a, 1b and 1c “Categories and Themes”). A content analysis was 
performed according to the constant comparison method, based on the grounded theory 
of Glaser & Strauss [15]. Data were extensively collected, coded and organized. The whole 
process of constant comparison leads to general conclusion(s) which can logically be derived 
from the data [17,18]. 



















































































































































Figure 1b: Categories and themes complex intervention








































Figure 1c: Categories and themes evaluation data
Results
Below, the results of the online survey (n = 19), the interviews (n = 4), the evaluation forms 
(n = 8) and the site notes (n = 5) are presented, using the format as depicted in box 2 [10]. 
See also Table 1 (demographic and clinical characteristics of the study population specified 
per institution). 
A. Study population
1. Recruitment and selection rate
A total of 187 patients were eligible to participate in the trial (see figure 2 flowchart). 124 of 
them declined participation due to refusing consent (n= 95), not meeting the inclusion criteria 
(n=14), poor compliance (n=10) or medical advice (n=5). Most of the recruitment was done 
by the nursing staff. This process was complicated and time consuming because most of the 
study’s target population, patients in the advanced stage of HD, had poor insight and could 
not fully understand the purpose, the process and the possible risks and benefits of the study. 
In most cases, their proxies (next of kin or legal guardian) had to be informed as well. This 
happened both through information-meetings with the principal researcher, or by one-on-one 
meetings or telephone-calls by either the principal researcher or the nursing staff. Besides 
that, a written document that gave a comprehensive explanation about the study’s protocol 
was handed out to all eligible patients and their proxies. 
Based on the statistical power calculation [1] we needed a minimum of 60 patients. 63 Patients 
or their proxies signed the informed consent: the recruitment objective was reached. 
2. Barriers and facilitators in recruitment and selection process
The most important reasons for participation was the willingness to dedicate time and effort 
to scientific research. Also, the love for music was a great motivator to sign up. The most 
important reason why (the proxies of) eligible patients declined participation was the heavy 
burden to participate in scientific trials. Another hindrance was the chance to be allocated, 
through randomization, in the control group instead of the music therapy group: some patients 
would refuse to participate in the latter. In the discussion section below we will elaborate on 
this topic.
Furthermore, in one of the participating centers, the room where the intervention was to take 
place was too small for patients in wheelchairs or beds, reason why some patients had to be 
excluded for participation beforehand.
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3. Follow-up: attrition rate
Based on the quantitative data, the number of missed intervention-sessions in the experi-
mental group (102/512) and in the control group (113/496) as well as missed assessments in 
the experimental group (19/256) and the control group (13/248) was practically equal. See 
also result C2.
4. Barriers and facilitators for follow-up
Reasons to miss sessions were: relocation to another facility (mentioned 4 times), mortality 
(3), lack of motivation (2), fatigue (1), comorbidity (1) or private circumstances (1). 
B. Multiple components of the complex intervention
1. Quality of delivery of the interventional components
All eight therapists, who were extensively instructed before the start of the study and who 
followed the same protocol, stated that the feasibility and the satisfactory of delivering the 
intervention components were dependent on the differences in the cognitive state of the par-
ticipating patients. For those patient whose cognition was not severely affected, the sessions 
could be tailor made. For the others, however, delivering the planned components was not 
feasible in many occasions. 
2. Barriers and facilitators for delivery of interventional components
The most important barrier for delivery and to fully benefit from the intervention, mentioned 
by all eight participating therapists, was the cognitive decline of the patients. Other barriers 
that were mentioned were equal to the reasons mentioned above why sessions were missed 
(see A4). 
An important barrier to deliver the intervention was the absence of the patients, due to the 
circumstances within the nursing homes: non-availability of the nursing staff to transport 
participants from the ward to the therapy room, broken elevators, or community-events (i.e. 
a concert or showing a movie) at the same time of the intervention. In one of the participating 
centers an extensive renovation was taking place at the same time as the study. This caused 
enormous noise pollution for both the experimental and control group. 
Based on the quantitative data derived from the observation forms, from the experimental 
group (MT), 22% of the participants followed fewer than 12 out of 16 sessions (n=7). For the 
control group (RT) this percentage was 23 (see table 1 and figure 2) (n=7). An attendance of 
> 75% can be accounted for in the analyses of the outcome measures. 
3. Adherence to interventional components
In both the experimental and control group, the interventional components were feasible to 
deliver to those patients who were actively involved. See B1.
4. Barriers and facilitators for adherence to interventional components
As mentioned above (see B2), the most obvious barrier for adherence was the low cognitive 
state some of the patients were in (mentioned by all eight therapists). Also, circumstances 
within the facility itself were important barriers for adherence.
 
5. Experience of participating therapists with intervention components
As mentioned above, the patients themselves did not receive questionnaires, hence they were 
not involved in the process-evaluation. According to the eight therapists who filled out the 
observation forms after each session, the patients with higher functioning cognition benefitted 
from the intervention, in that they enjoyed the sessions and that their communication and 
social interaction seemed to improve. 
All eight therapists felt a great commitment and involvement in the execution of the study. 
The protocol they had to follow was feasible, with enough opportunity to tailor it to meet the 
patient’s needs. As mentioned above, the biggest challenge for the therapists was the patients’ 
different cognitive state within the group. The overall opinion of the therapists was that the 
group size was small enough to warrant personal attention, despite this difference, while at 
the same time the group dynamic stimulated the social interaction of the patients. 
C. Evaluation data
1. Outcome measures: coverage of interventional components
To make sure that all assessments took place at the four different timepoints, in the week 
prior to the assessment weeks (at baseline, week 8, 16 and 28), the monitors sent a reminder 
to all assessors. Afterwards, the monitors checked if all the measurements had taken place. 
2. Completeness of data collection
The Behaviour Observation Scale Huntington (BOSH) [12] was considered easy to administer 
by the nursing staff. No instruction was needed prior to the first assessment. However, if two 
answers were filled out instead of one when the assessors were not convinced about the 
answer, the least beneficial one was entered into the statistical program. This happened 56 
times (0,8%).
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The assessors who administered the Problem Behaviours Assessment - short version (PBA-s) 
[13] had to follow a mandatory instruction-course, which they found very helpful. The fre-
quency of both measurements (every 8 weeks, 3 times in total and a follow-up assessment 
after 12 weeks) was considered feasible. 
For the experimental group, 7 BOSH-assessments and 12 PBA-s-assessments were missed. 
For the control group these numbers were 8 for the BOSH and 5 for the PBA-s-assessments. 
3. Barriers and facilitators for data collection
The frequency of both measurements (every 8 weeks, 3 times in total and a follow-up assess-
ment after 12 weeks) was considered feasible but time-consuming for all assessors. 
All four assessors that filled out the online survey stated that the PBA-s was more challenging 
to administer with the patients that were cognitively more declined. Besides that, for this tool 
a caregiver (nurse or proxy) had to be present to help answering the questions, which caused 
some more organization in planning. The assessors found the scoring of the PBA-s difficult, also 
due to the cognitive state of most of the patients. The mandatory training that they followed 
prior the study was considered very helpful.
Of the four participants who had administered the BOSH, one found the tool not sensitive 
enough for the more advanced patients. According to the assessors that filled out the survey, 
most important reasons why data were missing were participants moving to hospitals or other 
nursing homes or death. 
Finally, the research-assistant, who was responsible for the data-input, encountered incon-
sistencies in the scoring or the collection of the data in two of the facilities. These omissions 
were not always picked up by the monitors who were responsible for the final check of the 
data before input into SPSS, and who otherwise could have instructed the assessors to be 
more accurate when filling out the forms. 
Discussion and implications
Barriers and facilitators of the study population
Results from the process evaluation indicate that some patients refused to participate once 
they were allocated to the control group and not to the music therapy group. The information 
about the trial has to be unambiguous that no changes between allocation can be made once 
the patient is randomized.
Most RCT’s use usual care or no treatment as control condition [19]. The present study used 
an active control condition providing similar amounts of attention and group contact for both 
groups. 
When conducting an RCT, the presence or absence of the treatment must be the only differ-
ence between the treatment and control groups in order to prove that any therapy works. 
While this is almost never the case when comparing music therapy to other therapies [20] rec-
reational therapy was chosen as the control condition because being a complex, multi-faceted 
intervention as is music therapy, recreational therapy to us seemed to be the most appro-
priate control intervention to make the two groups as homogeneous in set-up and personal 
attention and thus as comparable as possible. The study-protocol unambiguously stated that 
no music activities were to be provided in the control group [2]. Apart from the intervention 
being compared, the groups were treated in an identical manner (i.e. day of the week, time 
of day, same “warm-up” and “cool-down” routine) and the same outcome data was obtained 
from all groups. Since the groups were randomly assigned and treated identically, apart from 
the intervention received, any differences in the outcomes are attributed to the difference in 
intervention [21,22].
However, randomization may not be appropriate if patients have a strong treatment prefer-
ence. If they do participate, their motivation to remain in the study may drop significantly 
after learning that they have been assigned to the control group [21]. This was the case in 
the present study.
Besides that, the cognitive problems, the lack of insight and the unawareness/anosognosia, 
known to patients with HD, often lead to poor treatment compliance [23, 24].
Furthermore, there seemed to be a discrepancy between the proxies’ expectation and the 
patients’ ability or willingness to participate in the study. This implicates that more clearness 
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has to be given, specifically to the proxies, about compliance to treatment and the burden to 
participate in the trial, and that inclusion of participants should specifically address appropri-
ateness for participation, including physical and cognitive limitations [10]. 
Despite having executed a block-permuted randomization to allocate the participating patients, 
a difference in cognitive function in each group could not be avoided. This seemed to have 
been the most obvious limitation for the professionals to work with. Adjusting the baseline 
scores (TFC, MMSE) in the inclusion criteria could have avoided this difference. Classifying/
dividing the groups on the basis of their baseline scores, however, will lead to non-homoge-
neous study-groups, and is therefore not desirable, nor is changing the cut-off score in the 
inclusion criteria, since the target group of this RCT are the more advanced HD-patients. 
Delivery of the intervention
Process evaluation of the complex intervention in this study show that adherence and com-
pliance leaves much to be desired, mostly due to comorbidity, mortality, relocation and 
circumstances on the ward where participants reside or the location of the therapy room in 
relation to the ward. 
The protocol should be clear about the location where the interventions are to take place; 
the treatment location should be close to the ward and accessible for all patients. A special 
consideration has to be given to caregivers’ availability to bring participants to and from the 
intervention room. Also, more emphasis should be placed on the importance of compliance, 
so that planning other events on the ward at the same time of the intervention will be avoided. 
The most important barrier for implementation of the intervention was the frailty of the par-
ticipants. The signs and symptoms of patients with HD are mostly multifactorial by cause and 
include cognitive decline. Besides, many patients are receiving psychotropic medication (see 
table 1), resulting in a state of low awareness of their surroundings. 
The most important challenge for implementation of the intervention was the fact that the trial 
took place in four different facilities, each with its own therapist. Even though all therapists fol-
lowed the same protocol, aiming for the same endpoints, the methods that were used varied 
in each house. The uniqueness of music therapy, however, i.e. the tailor-made interventions, 
allow this variety. The process-evaluation indicated that most therapists were satisfied with 
the delivery of their intervention, given the limitations they encountered as mentioned above.
Evaluation of the outcome measures
The process evaluation identified some limitations of the collection, evaluation and analyses 
of the outcome measures. 
Firstly, due to the fact that the patients were excluded for participation in the present evalua-
tion, determining their reactions to the intervention is purely based on the perception of the 
therapists, hence subjective and possibly biased. 
The BOSH [12] is an observation form that is completely filled out by caretakers, while the 
PBA-s [13] has to be filled out with the help of patients and proxies. The number of missed 
measurements however were almost the same for the BOSH as for the PBA-s. 
There are indications that the measurement tools that were used might not have fully matched 
the intervention outcomes (improvement of communicative and expressive skills and behavioral 
changes). In future designs, adjusting the outcome measures to anticipated goals is desirable. 
Strength and limitations
The strength of the presented process-evaluation is, that the participating professionals, nor 
the principle researcher, had any knowledge about the results of the effect-study (the RCT): 
these results were deliberately withheld until initial data collection and analysis of this pro-
cess-evaluation were complete, in order to prevent it from influencing the research findings.
The process evaluation identified a valuable facilitator in the fact that each participating center 
had a monitor, a point of contact attached to the study. This was very beneficial for the process 
of collection and input of the data. 
The subjectivity of the interviewees and the persons surveyed can be seen both as a limitation 
and as a strength of the present study. On the one hand they were to give answers concerning 
and on behalf of the participating patients, which could have led to bias. On the other hand, in 
qualitative research it is the subjectivity that matters the most, as social desirable responses 
are avoided. 
Scoring the MMSE [25] at baseline and after the last session (week 16) was considered 
extremely difficult, due to the severe cognitive state the patients were in. Besides, the scor-
ing was not consistent: some assessors (2) scored 0 where others (3) scored 99 (meaning the 
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score is missing). These missing data were set to zero to overcome this inconsistency in the 
scores between the houses. This may have led to a distorted image of the MMSE-outcomes. 
Instructions hereabout must have been better described in the protocol.
Finally, all participating professionals stated that they felt involved in and committed to both 
the process evaluation and the effect-study. At the same time, however, the contact with the 
principal researcher was sometimes laborious, due to the fact that the latter was not often 
present/visible on site. Most of the contact had to be maintained through internet. 
Conclusion and recommendations for future studies
Based on the results of the process-evaluation, the limitations in the present study are
- The cognitive state of the patients: the highly fluctuating physical and emotional responses 
to the intervention, and the diverse demographical, psychosocial and musical back-
grounds of the patients, mean that randomization is likely to be ineffective in distributing 
confounders evenly between groups.
- The use of quality of life outcome did not necessarily capture respondents’ characteris-
tic voices reflecting whether the experience was important to them. Furthermore, the 
treatment goal was the same for all participating patients: improving communicative and 
expressive skills. 
- The music therapy protocol could not be standardized, as music therapists tailor their 
approach according to patient’s need. 
- For future study designs, the following possibilities can be taken into consideration to 
avoid these barriers and limitations:
- Individual therapy sessions: the power of music therapy lies in the fact that the sessions 
can be tailor-made, meeting the individual needs of each patient [1, 2]. Taking the differ-
ences in cognitive state of the group-members into consideration, individual therapy to 
deliver the planned intervention components is recommended. 
- Using the Goal Attainment Scale (GAS) as the primary assessment tool: Goal attainment 
scaling is a mathematical technique for quantifying the achievement of personalized goals 
that are set for each individual that is included in the study [26]. 
- Using the Music therapy Assessment Tool for Advanced Huntington’s Disease (MATA-HD) 
as the secondary assessment tool. A pilot validation study of this newly developed tool 
has just finished in the UK [27]: preliminary data indicate that the MATA-HD is a promising 
tool for measuring patient responses to music therapy interventions across psychological, 
physical, social and communication domains of functioning in patients with advanced 
HD. The MATA-HD was not available yet when designing and executing the present study. 
- Furthermore, validated measurement tools that are sensitive for emotional and social 
cognitive responses in dementia might be suitable to use in future studies with HD-pa-
tients. 
- Designing a multiple single subject design study: this is a research design often used in 
applied fields of psychology and human behavior in which the subject serves as his/her 
own control, rather than using another individual or group. These designs are highly flex-
ible and highlight individual differences in response to intervention effects [28]. 
The demands for evidence of treatment efficacy and effectiveness are placing increased pres-
sure on the field of music therapy. Although the dialogue of clinical effectiveness in music 
therapy should not be dominated by the biomedical hierarchical model of evidence-based 
practice, “...despite the challenges of meeting all key design demands typical of an RCT, it is 
possible to design rigorous music therapy RCTs that accurately estimate music therapy treat-
ment benefits…” (Bradt, 2012, p. 120) [21].
Performing a multi-center RCT studying the efficacy of music therapy with vulnerable patients 
in a long-term care facility is feasible but challenging, if certain conditions are met and adjust-
ments made. No matter how complex the intervention and the study population, with an 
unambiguous written protocol, the right study design, outcome measures and assessment 
tools, and a continuous evaluation and monitoring throughout the whole study, barriers can 
be by-passed or avoided, and facilitators can be empowered.
When evaluating interventions that have the potential to improve quality of life, finding the 
best research designs and the best outcome measures for patients in the advanced stage of 
HD remains a major challenge. The biggest challenge for the music therapy researcher is to 
integrate different study-designs and to learn from the experiences of previous complex inter-
vention studies. This asks for all multidisciplinary team members surrounding the patient with 
Huntington’s disease to be willing to learn, to cooperate and to be creative [29]. 
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Abstract
This chapter reports about 2 patients with Huntington’s Disease who benefit greatly from 
music therapy while they are struggling with behavioral and emotional problems, due to the 
advanced stage of the disease. Huntington’s disease (HD) is an inherited neuropsychiatric 
disease with progressive neural degeneration of the basal ganglia and gradual atrophy of 
the frontal and temporal cortex. Symptoms are progressive and include motor, emotional 
and cognitive disturbance. There is as yet no cure for HD, nor can its progress be reversed or 
slowed down. All treatment is aimed at improving quality of life.
Music therapy is a non-pharmacological intervention to improve communication skills, reduc-
ing behavioral problems and thus leading to a better quality of life in patients with HD. There 
is little knowledge on how music therapy may contribute to improve the QoL in HD. This case 
report provides greater insight into how to treat patients with HD, especially in the advanced 
stage of the disease. 
Keywords: Huntington’s disease, quality of life, music therapy, case report
Case reports
Huntington’s disease (HD) is an inherited neuropsychiatric disease with progressive neural 
degeneration of the basal ganglia and gradual atrophy of frontal and temporal cortex [1]. 
Symptoms are progressive and include motor, emotional and cognitive disturbance. Despite 
the increase in number of therapeutic trials over the last 20 years, there is as yet no cure for 
HD, nor can its progress be reversed or slowed down [2,3].
Many of the patients present with language abilities that are inadequate to enable them to 
fully or sensitively express their feelings verbally. Dysarthria, dyspraxia, or aphasia result in 
poor articulation of words or difficulties in expressing language [4]. While speech itself is 
severely impaired, the thinking process of persons with HD, especially in the later stages, is 
often severely delayed. Also, poor insight, lack of awareness and denial, all due to cognitive 
decline associated with HD, imply that it is extremely difficult to create a coherent and mean-
ingful therapeutic relationship. In addition, persons presenting with rigid thought processes 
may have difficulty considering alternative viewpoints, solutions, or situations. Finally, many 
of the patients have a low self-awareness due to the use of psychotropic medication [1,2,3,4]. 
As long as there is no cure for HD, the emphasis of many of the treatments is on improving 
quality of life [3]. One of these non-pharmaceutical treatments offered to patients with HD in 
long-term care facilities is music therapy [5]. 
The American Music Therapy Association (AMTA) defines music therapy as follows: 
“Music therapy is the clinical and evidence-based use of music interventions to accomplish 
individualized goals within a therapeutic relationship by a credentialed professional who has 
completed an approved music therapy program” [6].
Music therapy uses music experiences and patient-therapist relationships in order to effect 
therapeutic change. Music therapists are part of the multidisciplinary team and participate in 
interdisciplinary treatment planning, ongoing evaluation, and follow-up [6]. They assess emo-
tional well-being, physical health, social functioning, communication abilities, and cognitive 
skills through musical responses. Music therapists design music sessions for individuals and 
groups based on client needs using music improvisation, receptive music listening, song writ-
ing, lyric discussion, music and imagery, music performance, and learning through music [7]. 
Applying music therapy to persons with Huntington’s disease is challenging, especially in the 
later stages of the disease, because of the aforementioned deficiencies. The following two case 
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reports illustrate the finding that music therapy can be successfully applied in persons with HD 
to help them with self-expression. The first report tells the story of a person with HD in whom 
music turns out to be the trigger for him to open up and show the man that he really is, as 
opposed to the patient with severe behavioral problems whom nurses are afraid to approach. 
The second report tells the story of another person with HD, whose lack of verbal communica-
tion hinders him from showing remorse towards a caregiver whom he has physically abused. 
Through therapeutic song-writing, he is offered the opportunity to rewrite the lyrics of a 
familiar song, personalizing it to his own experience.
Person A
A 64-year-old man in the late stage of Huntington disease was admitted to the long-term care 
facility. Because of severe behavioral problems, aggression, agitation and sexual disinhibition, 
he was treated with psychotropic drugs, the main side-effect being that he slept most of the 
day. Despite the medication, the negative behavior towards the nursing staff continued. Fur-
thermore, female nurses inadvertently triggered inappropriate sexual behavior. This resulted 
in a situation where most female nurses became afraid to approach him. His daily care was 
always carried out by at least two nurses, preferably one of them male. He could no longer 
express himself verbally, and so during his outbursts he would scream loudly and his involun-
tary movements would get worse.
One of the few personal items he brought with him, was his guitar. A phone call to his daughter 
revealed that in his younger years, he had been a pretty good “rock-and-roll” guitarist. Accord-
ing to his daughter, music had always been his one and only outlet. Taking all these facts into 
account, it was decided to start with music therapy to see if music could be the trigger for him 
to open up and express himself, with the aim of improving his behavior. 
During my first visit, he was sitting in a wheelchair. Abiding by the instructions from the care-
givers on the ward, the door of his room was left open for reasons of safety. Apart from 
greeting him and introducing myself, I did not talk much with him for the remainder of this 
first session that only lasted 15 minutes. I played my guitar and sang some songs that I thought 
would please him. Over the next few weeks, I slowly increased the duration of my visit and my 
guitar playing, and he seemed to get used to me gradually. I based my song-choices on the 
information I had about him: his age, the city where he was brought up, and knowing a little 
bit about his musical taste. As expected, there was no verbal reaction, but he seemed to calm 
down somewhat, showing fewer unwanted movements (chorea) and listening attentively to 
the songs.
I continued this procedure for the next three sessions, building trust and trying to create a 
safe environment. During the 4th session he requested a song that I had played for him in one 
of the previous sessions by mentioning the title of the song verbally. From that moment on I 
started a conversation about music. This first conversation, although very laborious, was the 
turning point in our therapy-sessions. He actually initiated talking about his love for music, 
and he started singing along with the lyrics that he was familiar with: I left out some words in 
the lyrics and he filled in the blanks. Obviously he was enjoying the sessions. After each song 
we talked about the lyrics, the artists, and the times when this particular song was a top-chart 
hit. We continued like this in weekly sessions. 
A couple of weeks later I decided to involve his own guitar in the session. I placed the guitar on 
his lap, and he held it tight against his chest. Although he could not play it himself anymore, 
I could see that he enjoyed just holding the instrument. When at the end of the session I 
returned the guitar to its case, I noticed a small piece of paper inside. Although it was almost 
illegible, the title of a song had been noted. It was a fairly obscure instrumental piece for the 
guitar, but I happened to know it well. During the next session I started to play this particular 
song; he lit up and started to cry. From that moment on he would ask me to play this particular 
song every session.
In the meantime, I decided to compile a CD with all the familiar songs that we played together. 
I advised the nursing staff to play this CD whenever he was getting agitated, or during stressful 
moments of the day (like bathing). 
I also videotaped him during the music therapy sessions to show my colleagues the “other 
side” of this person. This video footage brought about major changes in how the nurses on the 
ward would look at him. From that moment on, he was no longer the patient that nurses were 
afraid to take care of, nor was he the patient who was always alone in his room, isolated from 
the rest of the residents. He became involved in community events on the ward. Whenever it 
got too crowded for him, or whenever he showed signs of being too stressed, the nurses took 
him back to his room and left him to listen to a compilation CD of one of his favorite artists 
from “way back when”. 
When he passed away two years later, his daughter asked me to play a couple of his favorite 
songs during the funeral ceremony and people could watch the video footage of him singing 
along.
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The next case report describes another person in the advanced stage of Huntington’s Disease. 
For him, the song-writing method has proven beneficial on previous occasions. Song-writing 
in music therapy is a method whereby the therapeutic intervention consists of the process 
and product of writing a song with the client. Baker and Wigram [8] present a provisional 
definition: ‘The process of creating, notating and/or recording lyrics and music by the client 
and therapist within a therapeutic relationship to address psychosocial, emotional, cognitive 
and communication needs of the client’ (Baker and Wigram, 2005, p.16). 
The therapeutic effect is achieved through the client’s creation, performance and/or recording 
of his or her own song. The therapist’s role is to facilitate this process, ensuring that the clients 
create a composition that they feel they can own and that expresses their personal needs, 
feelings and thoughts. The product is something that the client can revisit, share with others, 
and that can be evidence of self-expression [8].
Experience tells us that it is better to use only familiar and preferred songs, rather than creating 
a completely new song. Because of the cognitive decline during the advanced stage, creating 
a completely new song might be a bridge too far. Also, by using a familiar melody line, any 
anxiety about the person’s musical capacity to perform the work will be minimized. “…And 
while no song that is created is entirely novel, each song typically tells a story in an original 
way…”(Marade (2007) in Baker, 2015, p.61, [9].
The case report below resembles that of many persons with HD who present with communi-
cation problems, cognitive impairments and rigidity/compulsive behavior. 
Person B
A 58-year-old man with Huntington’s disease who had been institutionalized for three years 
in the long-term care facility, was chosen to join a small group of fellow residents at a 4-day 
summer-camp. 
After one day, the physician of the facility received a phone call from one of his caregivers, 
telling him that the man had completely lost it. He had shown aggressive and agitated behavior 
and had physically attacked one of the nurses. The reason for this outburst was because he 
was told not to smoke in his bedroom, and having ignored this, his cigarettes were taken away. 
He was sent home the next day as his behavior had not improved, despite medication to calm 
him. Upon arrival in the nursing home, he was still very agitated. The psychologist who met 
with him did not manage to talk any sense into him. He did not seem to understand that his 
behavior was intolerable, nor did he show any remorse for having abused the nurse. He kept 
screaming and was very upset that he had been sent home. 
The physician asked me if I could possibly calm him by playing his favorite music or his self-
made songs. 
I had known him for over a year by this time; he had been receiving individual music therapy 
once every week. He is known for not being able to show or express his emotions verbally, 
although he does have the urge to do so. Music therapy has proven beneficial for him. One of 
the methods that we often use is analyzing or writing song lyrics to improve communication 
and expression. 
When he came to me, the first thing we did was just listen to some of his old-time favorites 
while I played along on my guitar. We didn’t talk at first, we just enjoyed listening to the music 
together. After a couple of songs, I started talking about what actually happened. As expected, 
he could not find the right words to express himself. I then grabbed my guitar and started 
playing a well-known Dutch song. We talked about the metaphoric meaning of these lyrics, 
how your thinking gets clearer if you let go of negative and angry feelings. But I also took part 
of the lyrics literally and “translated” this into how his nicotine-addiction and compulsion for 
smoking cigarettes had taken over at the summer-camp, the reason why he went completely 
out of his mind. During our conversation he opened up, and I showed empathy when we 
started talking about what had happened. At the same time, however, we talked about the 
fact that his behavior could not be tolerated. He told me that he realized this, and that he was 
very sorry about what had happened, and that he felt very sorry for the nurse he attacked. He 
wanted to apologize to her, but he did not know how.
I suggested that we could rewrite this particular song in his own lyrics to express his regrets. 
He seemed to like this idea. I formatted what he had just said to me into new lyrics, making 
sure to use exactly the wording that he used, without changing it a bit. My only job was to 
make his words fit into the cadence of the song so he could sing along.
 After a while, he thought the lyrics were “perfect”. We sang the song a couple of times, 
and when he was completely satisfied I suggested that we could record the song. We did so 
the next day, and I burned the song on several CDs, giving him the opportunity to give one 
to the nurse whom he had attacked. For him, this was the only way to show his regrets and 
apologize to her. For the nurse, this was the best way to realize that it was the patient who 
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had attacked her, but it was the person who had created a song for her to show his regret 
and bury the hatchet.
The two stories above are examples of persons with HD who benefit from music therapy.
As the ability to communicate and express oneself deteriorates over time, music therapy could 
play an important role in the treatment of persons with HD in all phases of the disease [10]. 
By providing an additional means of communication, thus enabling the patient to express 
emotions, “(…) meaning is conveyed through the combination of lyrics and music. Lyrics clearly 
have a capacity to communicate, in a concrete way, the events that are core to the song. But 
music can also be key in conveying intended meaning…” (Baker, 2015, p.75 [4 ).
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Summary
Huntington’s disease (HD) is an inherited, progressive, neurodegenerative disease that is 
characterized by a triad of motor, cognitive, and psychiatric problems. The motor distur-
bance mainly consists of characteristic unwanted movements. The cognitive changes affect 
concentration, memory, executive functions, and acquisition of new information. Emotional 
disturbance often appears before the onset of motor or cognitive problems, and depression, 
irritability, impulsiveness and anxiety are common symptoms [1,2,3].
Due to the physical and cognitive skills, communication skills are gradually deteriorating, which 
contributes to a sometimes rapidly increasing inability to participate in different life situations 
[4]. This has a huge impact on the autonomy of the patient, often leading to an increase of 
behavioral problems. As a result, the quality of life (QoL) deteriorates along the progression 
of the disease. While there is no cure for the disease, the emphasis should be on the care of 
the patients, and more specifically on improvement or consolidation of their quality of life [4]. 
Music therapy is a non-pharmacological intervention that may have beneficial effects on 
improving communication and expressive skills in patients with HD. It is hypothesized that by 
improving these skills, the behavioral problems will improve, leading to an overall improve-
ment of the QoL of patients with HD [5]. The general aim of this thesis was to determine 
whether this hypothesis could be confirmed through an experimental, quantitative study.
The first goal was to review the literature to define the state of knowledge on music therapy 
(MT) for patients with Huntington’s disease (Chapter 2). This review revealed a paucity of lit-
erature on this topic. Precise aims and methods in relation to the stage of the disease, mostly 
derived from small scaled observational studies, are not well determined. This confirmed our 
assumption that there was a need to study the effectiveness of MT in this population. 
Subsequently, we conducted a focus group study to investigate whether six experienced cli-
nicians from different disciplines recognized a possible beneficial role for the music therapist 
at improving the QoL in patients with HD. The outcome of this study, described in chapter 3, 
revealed that the QoL-issues that were most mentioned, were psychosocial aspects, with sense 
of security, confidence and structure being the qualifications most outstanding. According to 
the focus group participants, as the ability to communicate and express oneself deteriorates 
over time, MT could play an important role in the treatment of patients with HD in all stages 
of the disease.
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The insights of the focus group participants along with the literature review described in 
chapter 2 were used to design an empirical trial looking at the effects of MT on improving 
the quality of life of patients with HD by improving their communication skills. We designed a 
quantitative randomized controlled trial (RCT). This study was the first RCT with music therapy 
in patients with Huntington’s disease with a large number of participating patients in the late 
stage of their disease. The design of this study is described in chapter 4.
The results of this single-blinded, multi-center randomized controlled trial are described in 
Chapter 5. Sixty-three HD-patients, admitted to four long-term care facilities in The Nether-
lands, were randomized to receive either group music therapy or group recreational therapy 
in 16 weekly sessions. The primary outcome measure was the communicative and expressive 
skills. The secondary outcome measure was problem behavior. Assessments took place at 
baseline, after 8, 16 and 28 weeks using (subscales of) the Behaviour Observation Scale for 
Huntington (BOSH) [6] and the Problem Behaviours Assessment-short version (PBA-s) [7]. A 
linear mixed model with repeated measures was used to compare the scores between the 
two groups. 
The results of this study revealed that the beneficial effects of music therapy, recorded in 
many, mainly qualitative case reports and studies, could not be confirmed with the design 
and outcome measures we used in our study. 
Before starting the trial we planned to perform a comprehensive process-evaluation alongside 
the effect study to investigate how the study was performed and to elucidate the results of the 
effect study. This evaluation, described in chapter 6, revealed several barriers and limitations of 
the study concerning (1) the characteristics of the source population, (2) the research methods 
and the outcome measures that were used, and (3) the set treatment goals. In the discussion 
below we will elaborate on these barriers and limitations, resulting in recommendations for 
future studies in regard to design and measurement tools. 
Due to the vulnerability of the study population, in none of the aforementioned qualitative 
studies (i.e. the focus group study and the process-evaluation) the patient himself was directly 
involved. For this reason, giving the patient a face and a voice, and to show insight in the 
real-world context in which music therapy is practiced, two case-reports of patients with a 
successful response were described in chapter 7.
Discussion
The beneficial effects of music therapy could not be proven with the design and outcome 
measures that have been used in the present effect study [8]. This outcome could imply that 
either music therapy is not effective in HD, or that the chosen study design or the primary 
endpoints (communication and expressive skills and behavior) were not appropriate to show 
the effectiveness of music therapy. 
Study design
When the efficacy of healthcare interventions has to be evaluated, the randomized controlled 
trial (RCT) is commonly accepted as the gold standard. Being the first study to assess the effect 
of group music therapy in advanced stage HD patients, the major strength of the present study 
is that an active control group receiving recreational therapy was involved. In most studies, 
the control group receives treatment as usual or no treatment.
The process-evaluation revealed the following limitations: 
1. Randomization: the diversity of the clinical expression of HD and the characteristics of 
the source population mean that randomization is likely to be ineffective in distributing 
confounders evenly between groups [9].
2. As the study took place in four different facilities, we decided to do a center-stratified, 
block-permuted randomization to generate the random allocation sequence and to min-
imize the impact of any between-center differences on the trial results [10]. Taking the 
patients’ feasibility and willingness to participate in the study into consideration, due to 
their cognitive deterioration, their highly fluctuating physical and emotional responses to 
treatment, and their diverse demographical, psychosocial and musical backgrounds, we 
anticipated a small group-size with a maximum of 5 participants.
3. Outcome measures: the set treatment goals (improving communicative and expressive 
skills) was the same for all participating patients.
4. Assessment tools: there are indications that the assessment tools that were used might 
not have been sensitive enough to capture changes in the intervention’s primary and 
secondary endpoints (communication and expressive skills and behavior). 
5. Below we will elaborate on these limitations, which are all conflicting with the definition 
of music therapy [4,5] in which it is specifically stated that treatment goals are to be indi-
vidualized, addressing the patient’s functional goals and adapted to their functional level. 
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The outcome measures in our study were chosen, based upon the premise that improving the 
communicative and expressive skills of the patients would lead to improvement of behavior, 
eventually leading to improvement of the patient’s quality of life [5]. 
The choice for the BOSH and the PBA-s as assessment tools was based on the expectation that 
the items of these tools would detect changes in the chosen outcome measures [8]. However, 
according to the assessors who participated in the process evaluation [11] and in line with 
the literature [6,12], due to the cognitive state of the participants these tools might not have 
been sensitive enough to capture what we intended to measure. Besides that, a large floor 
effect could have been expected due to the nature of the study population for the PBA-s [13]. 
A paucity of efficacy studies of non-pharmacological interventions in HD may be a reflection 
of the lack of disease-specific standardized assessment tools for collecting consistent and 
reliable information relating to the clinical effects of interventions across the disease progres-
sion [12]. 
The existing standard tool that is used for clinical assessments (UHDRS) is considered to lack 
sensitivity to marginal clinical effects, particularly with regard to cognitive and psychiatric 
symptoms in the late stages of the disease [14]. A new scale, the UHDRS-FAP (For Advanced 
Patients) was developed in 2013 and appears to be more sensitive to change than the original 
UHDRS for cognitive and motor domains. The UHDRS-FAP is the only scale that detects decline 
in patients with a TFC-score ≤ 1, indicating a very low cognitive functionality. The tool was not 
validated yet when the present study was designed and executed. 
Recently, a disease specific assessment tool for music therapy was developed for patients with 
advanced HD: The Music therapy Assessment tool for Advanced HD (MATA-HD) [12]. Since 
there is no evidence yet to support whether musical behaviors and responses in advanced 
HD bear any relationship to physical, psychological or social domains [12] a valid assessment 
tool capturing both musical and non-musical behaviors may reveal whether such relationships 
exist. The tool includes a total of 15 items across six subscales: arousal/attention, physical pre-
sentation, communication, musical, cognition and psychological/behavioral. 11 of the 15 items 
have a shared focus of engagement in therapy, while the good construct validity demonstrated 
by the communication items highlights the robustness of the tool in this important area. This 
is the first tool to guide clinical practice and assess responses to music therapy intervention. A 
pilot validation study of this newly developed tool has just finished in the UK [12]: preliminary 
data indicate that the MATA-HD is a promising tool for measuring patient responses to music 
therapy interventions across psychological, physical, social and communication domains of 
functioning in patients with advanced HD. The MATA-HD was not available yet when designing 
and executing the present study. 
Adjusting the outcome measures to anticipated individualized goals, as stated in the aforemen-
tioned definition of music therapy, is desirable. Besides that, in advanced HD-patients the floor 
effects of the assessment tools mentioned above hamper the evaluation of these tools, thus 
calling for an adjusted scale. The Goal Attainment Scale (GAS) [15] is an eligible assessment 
tool: goal attainment scaling is a mathematical technique for quantifying the achievement of 
personalized goals that are set for each individual that is included in the study [16]. It must 
be noted that setting individual goals is challenging, specifically for patients with HD who are 
known to have poor insight in their condition [5], due to the cognitive decline. 
Improvement of study design
Although the dialogue of clinical effectiveness in music therapy should not be dominated by 
the biomedical hierarchical model of evidence-based practice, Bradt [16] states that it is pos-
sible to design rigorous music therapy RCTs that accurately estimate music therapy treatment 
benefits if certain conditions are met and adjustments made. No matter how complex the 
intervention and the study population, with an unambiguous written protocol, the carefully 
and accurately chosen outcome measures and assessment tools, and a continuous evalua-
tion and monitoring throughout the whole study, barriers can be by-passed or avoided, and 
facilitators can be empowered [16]. 
Different research questions demand different types of research methods and evidence [16]. 
Experimental studies with quantitative outcome measures stay important for clinicians and 
policy makers. Quantitative data alone however give insufficient information to come to a 
good judgement concerning the effects of a complex intervention and the impact these effects 
have on the patients. 
When developing a complex intervention, it is important to consider the context and circum-
stances in which the intervention will be executed. Often, observational or qualitative research 
is necessary preceding the RCT to clarify which aspects of the problems are appropriate to 
reach the set goals. When designing such interventions, knowledge of the context is essen-
tial and using qualitative or observational studies alongside the quantitative experiment may 
support meeting the set goals [17]. 
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In the present study, the above-mentioned recommendations were met for the most part: 
preceding the RCT a comprehensive literature study was executed [4], followed by a qualitative 
study using focus group discussions [5]. Alongside the present RCT we performed a process 
evaluation using a mixed method of qualitative and quantitative data [11]. 
Recommendations for improvements or adjustments for the clinical practice and future studies 
are made below.
Future perspectives
For future study designs, the following possibilities can be taken into consideration to avoid 
the barriers and limitations that were encountered:
- Executing a pilot or feasibility study [16]: during the pilot study, issues related to study 
recruitment, attrition, and treatment adherence can be explored, and preliminary data 
on treatment efficacy can be obtained. During this phase, the research team develops 
the treatment manual, the protocol for training study personnel, and treatment fidelity 
procedures.
- Individual therapy sessions: the care for vulnerable patients as the ones with HD demands 
an individual approach in order to meet the complex needs of these patients. Taking the 
differences in cognitive state of the group-members into consideration, individual therapy 
to deliver the planned intervention components is recommended. 
- The power of music therapy lies in the fact that the sessions can be tailor-made, meeting 
the individual set goals of each patient [4,5]. The use of the aforementioned GAS assess-
ment tool [15] is recommended to set these goals. 
- Other good alternatives for future studies might be the use of the aforementioned 
UHDRS-FAP (Unified Huntington’s Disease Rating Scale - For Advanced Patients) [14] or 
the MATA HD (Music therapy Assessment Tool for Advanced HD) [12] after being validated. 
- Designing a multiple single subject design study: this is a research design often used in 
applied fields of psychology and human behavior in which the subject serves as his/her 
own control, rather than using another individual or group. These designs are highly flex-
ible and highlight individual differences in response to intervention effects on different 
domains [18]. With single-case course studies we comprehend the process of change of 
clients or patients with regard to the complexity of music therapy [19]. 
- Involving family members: in future research designs, the involvement of caregivers in the 
experiment should be taken in consideration, as this will help improve communication 
skills between the patient and his caregiver outside of the music therapy [5]. This will be 
the most beneficial outcome and will undoubtedly lead to improvement of the QoL for 
both patient and caregiver [5]. Also, the voice of the HD patient and caregiver can be an 
invaluable resource in helping to determine directions for clinical trials [20]. 
In order to prove the effectiveness of music therapy, the randomized controlled trial (RCT) as 
a “stand-alone” study is not the appropriate research design unless it is preceded by, executed 
alongside or supplemented with other observational or qualitative studies and unless the most 
eligible and feasible endpoints are being chosen and assessment tools are being used (see the 
aforementioned recommendations). 
Conclusion 
When evaluating interventions that have the potential to improve quality of life, finding the 
best study design and the best outcome measures for patients in the advanced stage of HD 
remains the major challenge. The challenge for the music therapy researcher is to find alter-
native study-designs and to learn from the experiences of other complex intervention studies. 
This asks for all multidisciplinary team members surrounding the patient with Huntington’s 
disease and academic scholars to be willing to learn, to cooperate and to be creative [17]. 
In an effort to contribute to the evidence base of music therapy through RCT-research (based 
on the aforementioned assumption of the RCT being the gold standard research design to 
prove the efficacy of healthcare interventions), this design was chosen for the present study. 
Performing a multi-center RCT studying the efficacy of music therapy with vulnerable patients 
in a long-term care facility turned out to be feasible but challenging.
However, in the practice of music therapy, the rules that apply for conducting a RCT, where 
the intervention to be studied must be standardized in order to compare the intervention 
and the control group, are considered impediments or difficulties to be overcome [9,21]. The 
definition of music therapy, stating that goals are to be adapted to the clients’ functional level 
to accomplish individualized goals are in conflicting with the RCT-rules. 
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The added value of music therapy is that the intervention can be adjusted to the individual 
needs and possibilities of the patient. The individualized way of engaging with music in ther-
apy is what makes the therapy effective. Therefore, it is not the content of the intervention 
that should be standardized, but the function of the intervention. In so doing, the therapists 
are free to integrate any techniques or method to reach specific goals while following a stan-
dardized process [9,21].
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De Ziekte van Huntington (ZvH) is een aangeboren, erfelijke, progressieve, neurodegene-
ratieve aandoening die wordt gekenmerkt door motorische, cognitieve en psychiatrische 
problematiek. De motorische beperkingen bestaan voornamelijk uit ongewilde bewegingen. 
De cognitieve veranderingen hebben voornamelijk betrekking op concentratie, geheugen, 
executieve functies, en het verwerven van nieuwe informatie. Emotionele stoornissen dienen 
zich vaak al voor de motorische en cognitieve problemen aan. Depressie, irritatie, impulsiviteit 
en angst zijn veel voorkomende symptomen [1-3].
Als gevolg van de fysieke en cognitieve achteruitgang gaan ook de communicatieve vaardig-
heden achteruit. Een soms snelle achteruitgang van deelname in het alledaagse leven en het 
kunnen omgaan met situaties die bij het leven horen is hier weer het gevolg van [4]. De zelf-
standigheid van de patiënt komt hiermee in het gedrang, hetgeen vaak leidt tot een toename 
van gedragsproblemen. Zo vermindert de kwaliteit van leven (KvL) naarmate de ziekte vordert. 
Zolang er nog geen genezing voor de ziekte is, ligt de nadruk op de zorg (care versus cure) 
voor patiënten met de ZvH, met als specifieke doel het in stand houden en verbeteren van 
de kwaliteit van leven [4]. 
Muziektherapie is een niet-medicamenteuze interventie die mogelijk gunstige effecten heeft 
op het verbeteren van de communicatieve en expressieve vaardigheden voor patiënten met 
de ZvH. Verondersteld wordt, dat verbetering van genoemde vaardigheden zal leiden tot ver-
betering van het gedrag, hetgeen weer leidt tot algehele verbetering van de KvL van patiënten 
met de ZvH [5]. 
De algemene doelstelling van dit proefschrift was om te bepalen of deze veronderstelling 
bevestigd kan worden middels het uitvoeren van een experimenteel kwantitatief onderzoek.
De eerste doelstelling was om middels een literatuuronderzoek te achterhalen wat de stand 
van zaken is m.b.t. kennis van muziektherapie voor patiënten met de ZvH (Hoofdstuk 2). Dit 
onderzoek bracht een schaarste aan het licht over genoemd onderwerp. De meeste artikelen 
betreffen kleinschalige, observationele studies. Doelstellingen en in te zetten methodieken in 
relatie tot de verschillende stadia van de ziekte zijn in deze artikelen niet nauwkeurig omschre-
ven. Deze conclusie bevestigde onze aanname dat een onderzoek naar de effectiviteit van 
muziektherapie bij deze patiëntenpopulatie nodig is. 
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Vervolgens voerden we een focusgroep-studie uit om te onderzoeken of zes Huntington-erva-
ringsdeskundigen vanuit verschillende klinische disciplines een mogelijke waardevolle rol voor 
de muziektherapeut weggelegd zagen om de KvL van patiënten met de ZvH te verbeteren. 
Uit de resultaten van deze studie, beschreven in hoofdstuk 3, komt naar voren dat psychoso-
ciale aspecten de KvL het meest beïnvloeden. Gevoel van veiligheid, vertrouwen en structuur 
waren de kwalificaties die het meest genoemd werden. De focusgroep-deelnemers waren van 
mening dat muziektherapie een belangrijke rol kan spelen in de behandeling van patiënten 
met de ZvH wanneer het vermogen om te communiceren en zichzelf uit te drukken minder 
wordt naarmate de ziekte vordert. 
De in hoofdstuk 2 en 3 beschreven inzichten vanuit de literatuur en van de focusgroep-deel-
nemers werden vervolgens gebruikt om een experimenteel onderzoek naar de effecten van 
muziektherapie op te zetten. Het hoofddoel van dit onderzoek was het verbeteren van de 
KvL van patiënten met de ZvH door het verbeteren van communicatieve vaardigheden. We 
ontwikkelden een gerandomiseerd, gecontroleerd onderzoeksdesign (randomized controlled 
trial=RCT). Dit was de eerste RCT waarbij muziektherapie met een groot aantal patiënten 
in het gevorderde stadium van de ZvH werd uitgevoerd. Het design van deze studie wordt 
beschreven in hoofdstuk 4.
De resultaten van deze enkelvoudig-geblindeerde, multicenter RCT staan beschreven in 
hoofdstuk 5. Drieënzestig patiënten verblijvend in vier verschillende verpleeghuizen voor 
langdurige zorg in Nederland, allen gespecialiseerd in de zorg voor patiënten met de ZvH, 
werden middels randomisatie aan de interventiegroep (muziektherapie) of aan de controle-
groep (activiteitenbegeleiding) toegewezen. Beide groepen hadden 16 maal een wekelijkse 
sessie. De primaire uitkomstmaat waren de communicatieve- en expressieve vaardigheden. 
De secundaire uitkomstmaat was het probleemgedrag. Metingen vonden plaats op baseline 
en vervolgens na 8, 16 en 28 weken. Hierbij werd gebruik gemaakt van de Gedrags Observatie 
Schaal voor Huntington (GOSH) [6] en de Problem Behaviours Assessment-short meetschaal(P-
BA-s) [7]. Om de scores van de twee groepen met elkaar te vergelijken werd gebruik gemaakt 
van een statistische techniek volgens het “linear mixed model with repeated measures”-mo-
del. 
De gunstige effecten van muziektherapie, zoals gerapporteerd in vele kwalitatieve onderzoe-
ken en case-reports, konden met de door ons gekozen uitkomstmaten en meetinstrumenten 
niet bevestigd worden. 
Tegelijkertijd bereidden we een uitgebreide procesevaluatie voor om te onderzoeken hoe de 
RCT was uitgevoerd en om hiermee de resultaten van de studie tegen het licht te houden. Deze 
evaluatie, beschreven in hoofdstuk 6, bracht verschillende struikelblokken en beperkingen 
van de studie aan het licht. Deze beperkingen betroffen (1) de karakteristieken van de onder-
zoekspopulatie, (2) de studie-methode en de uitkomstmaten, en (3) de behandeldoelen. In 
de onderstaande discussie wordt hierop ingegaan en worden aanbevelingen voor de praktijk 
en toekomstige studies gedaan. 
Vanwege de kwetsbaarheid van de onderzoekspopulatie was de patiënt zelf in geen van de 
hiervoor genoemde kwalitatieve onderzoeken (focusgroep en procesevaluatie) direct betrok-
ken. Om die reden hebben we in hoofdstuk 7 in een case-report twee patiënten beschreven 
waarbij muziektherapie succesvol wordt ingezet. De patiënt krijgt een stem en een gezicht. 
Tegelijkertijd wordt een inkijk gegeven in de dagelijkse praktijk van de muziektherapeut. 
Onderzoeksopzet
Wanneer de effectiviteit van interventies in de gezondheidszorg moeten worden geëvalueerd, 
wordt de RCT in het algemeen beschouwd als de “gouden standaard”. 
Dit is het eerste onderzoek naar de effecten van muziektherapie bij patiënten in het ver-
gevorderde stadium van de ZvH. In veel RCT’s wordt de interventie vergeleken met een 
controlegroep waarin geen interventie wordt aangeboden of waarbij de interventie wordt 
vergeleken met de standaard aangeboden zorg. In deze studie kreeg de controlegroep activi-
teitenbegeleiding aangeboden onder dezelfde omstandigheden en volgens hetzelfde protocol 
als de muziektherapiegroep. 
Uit de procesevaluatie die werd uitgevoerd kwamen de volgende beperkingen naar voren: 
1. Door de klinische verscheidenheid van de ZvH en de karakteristieken van de onder-
zoekspopulatie is het aannemelijk dat, ondanks randomisatie, geen evenredige verdeling 
van verstorende variabelen (confounders) tussen de beide groepen werd bereikt [9].
2. Omdat de studie plaats vond in vier verschillende zorginstellingen hebben we besloten 
om een gestratificeerde gepermuteerde blok-randomisatie uit te voeren, waarbij elke 
deelnemende zorginstelling een apart stratum vormde. Hiermee beoogden we verschillen 
tussen de centra onderling te voorkomen [10]. 
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De groepsgrootte van minimaal drie en maximaal vijf werd bepaald op basis van de haalbaar-
heid en de bereidwilligheid van de patiënt om deel te nemen. De cognitieve achteruitgang, de 
sterk fluctuerende fysieke en emotionele reactie op de behandeling en de diverse demografi-
sche, psychosociale en muzikale achtergrond van de patiënt waren hierin leidend. 
3. De vooropgestelde behandeldoelen (verbetering van de communicatieve en expressieve 
vaardigheden) waren dezelfde voor alle deelnemende patiënten.
4. Er zijn aanwijzingen dat de gebruikte meetinstrumenten niet sensitief genoeg waren om 
veranderingen te detecteren in de primaire en secondaire uitkomstmaten (communica-
tieve en expressieve vaardigheden en gedrag). 
5. Onderstaand volgt een gedetailleerde uitweiding over de bovengenoemde beperkingen. 
In de definitie van muziektherapie van de American Music Therapy Association (AMTA) [4,5] 
staat expliciet geschreven dat behandeldoelen moeten worden toegespitst op het individu, 
daarbij rekening houdend met en aangepast aan de vermogens van dit individu. De keuze 
van dezelfde behandeldoelen en uitkomstmaten voor elke deelnemende patiënt conflicteert 
met deze definitie. 
De uitkomstmaten werden gekozen op basis van de aanname dat verbetering van commu-
nicatieve en expressieve vaardigheden van de patiënt leidt tot verandering van het gedrag, 
hetgeen uiteindelijk leidt tot verbetering van de KvL [5].
De keuze van de GOSH en de PBA-s als meetinstrumenten was gebaseerd op de verwachting 
dat de items van deze instrumenten veranderingen in de gekozen uitkomstmaten zouden 
kunnen detecteren [8]. De assessoren die deelnamen aan de procesevaluatie waren echter 
van mening dat dit, gezien de (vaak slechte) cognitieve staat waarin de patiënten verkeerden, 
niet het geval was [11]. Deze mening is in overeenstemming met wat in de literatuur staat 
beschreven over de GOSH en de PBA-s [6,12]. Daarnaast was bij de onderzoekspopulatie een 
hoog bodem-effect te verwachten [13]. 
Er is een tekort aan ziekte-specifieke gestandaardiseerde meetinstrumenten om consistente 
en betrouwbare informatie betreffende de klinische effecten van interventies van de ziekte te 
verzamelen. Dit gegeven reflecteert wellicht de schaarste aan experimentele studies naar de 
effecten van niet-medicamenteuze interventies bij patiënten met de ZvH [12]. 
Van het huidige meetinstrument dat wordt gebruikt voor klinische evaluaties, de Unified Hun-
tington’s Disease Rating Scale (UHDRS), wordt verondersteld dat deze de gevoeligheid mist 
voor de marginale klinische effecten, met name op het gebied van cognitieve en psychiatrische 
symptomen in het vergevorderde stadium van de ziekte [14]. Als antwoord hierop werd in 
2013 een nieuwe meetschaal ontwikkeld die gevoeliger lijkt te zijn voor veranderingen binnen 
de cognitieve en motorische domeinen. Deze nieuwe schaal, de UHDRS-FAP (For Advanced 
Patients) is de enige schaal die achteruitgang detecteert bij patiënten met een TFC (Total 
Functional Capacity)-score ≤ 1, hetgeen duidt op een zeer lage cognitieve functionaliteit. 
Het instrument was nog niet gevalideerd ten tijde van het ontwerpen en uitvoeren van de 
onderhavige studie. 
Recent werd een ziekte-specifiek meetinstrument voor muziektherapie ontwikkeld voor pati-
enten in het gevorderde stadium van de ZvH: de Music therapy Assessment Tool for Advanced 
HD (MATA-HD) [12]. Of er een relatie bestaat tussen het muzikaal gedrag en de muzikale 
gevoeligheid van patiënten in het vergevorderde stadium van de ZvH en eigenschappen op 
het fysieke, psychologische en sociale vlak, heeft men tot op heden nog niet kunnen aanto-
nen [12]. Een meetinstrument als de MATA-HD dat zowel muzikaal als niet muzikaal gedrag in 
kaart kan brengen, kan de oplossing zijn om een dergelijke relatie aan te tonen. De voorlopige 
resultaten geven aanwijzingen dat de MATA-HD een veelbelovend instrument is om de reacties 
van patiënten in het gevorderd stadium van de ZvH op muziektherapie-interventies te meten, 
en om aan de hand hiervan een uitspraak te kunnen doen omtrent het functioneren op psy-
chologisch, fysiek, sociaal en communicatief vlak. De MATA-HD, die in de nabije toekomst nog 
gevalideerd moet worden (zie ook “future perspectives”), was nog niet beschikbaar ten tijde 
van het ontwerpen en uitvoeren van de onderhavige studie.
Conform de hiervoor genoemde definitie van muziektherapie is het wenselijk om de uit-
komstmaten af stemmen op de individuele doelen. Daarnaast bemoeilijkt het bodemeffect 
bij patiënten in het gevorderde stadium van de ZvH van de genoemde meetinstrumenten 
deze te evalueren. 
In dit licht bezien is de Goal Attainment Scale (GAS) [15] een geschikt meetinstrument: de GAS 
maakt gebruikt van een mathematische techniek die het bereiken van individuele doelen, die 
voor elk persoon die deelneemt in het onderzoek zijn vastgesteld, kwantificeert [16]. Hierbij 
moet opgemerkt worden dat het vaststellen van individuele doelen uiterst moeizaam kan zijn 
voor patiënten met de ZvH gezien het slecht ziekte-inzicht en het feit dat ze zich niet bewust 
zijn van hun conditie als gevolg van de cognitieve achteruitgang [5]. 
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Verbetering van de onderzoeksopzet
De dialoog aangaande de klinische effectiviteit van muziektherapie moet niet gedomineerd 
worden door het biomedische hiërarchische model van de Evidence Based Practice (EBP). 
Volgens Bradt [16] is het mogelijk een strikte RCT te ontwikkelen die een accurate inschatting 
maakt van de voordelen van de muziek-therapeutische behandeling, mits aan bepaalde con-
dities en aanpassingen wordt voldaan. Hoe complex de interventie en de onderzoekspopulatie 
ook is, met een eenduidig protocol, zorgvuldig gekozen uitkomstmaten en meetinstrumenten 
en een voortdurende evaluatie en monitoring gedurende het hele onderzoek kunnen struikel-
blokken worden voorkomen, en kunnen facilitatoren worden verbeterd [16]. 
Verschillende onderzoeksvragen vergen verschillende types onderzoeksmethodieken en evi-
dentie [16]. Experimentele studies met kwantitatieve uitkomsten blijven belangrijk voor clinici 
en beleidsmakers. Echter, de kwantitatieve uitkomsten alleen geven onvoldoende informatie 
om tot een goede inschatting te komen van de effecten van een complexe interventie en om 
te bepalen welke uitwerking deze effecten hebben op de patiënt. 
Wanneer men een complexe interventie ontwikkelt, is het belangrijk om met de context en de 
omstandigheden waarin de interventie wordt uitgevoerd rekening te houden. Vaak is observa-
tioneel of kwalitatief onderzoek voorafgaande aan de RCT noodzakelijk om duidelijk in kaart te 
brengen welke aspecten van de problemen relevant adequaat zijn om de doelen te bereiken 
[17]. 
Deze adviezen zijn in de huidige studie grotendeels opgevolgd: voorafgaand aan de RCT werd 
een uitgebreide literatuurstudie uitgevoerd [4], gevolgd door een kwalitatieve focusgroep-stu-
die [5]. Aansluitend aan de RCT werd een procesevaluatie uitgevoerd, waarbij gebruik werd 
gemaakt van een combinatie van zowel kwalitatieve als kwantitatieve onderzoeksgegevens 
[11]. Aanbevelingen voor verbeteringen of aanpassingen voor de klinische praktijk en toe-
komstige onderzoeken volgen hieronder.
Toekomstperspectieven
De volgende mogelijkheden kunnen in overweging genomen worden om struikelblokken en 
beperkingen die in de huidige studie werden tegengekomen, te voorkomen.
- Uitvoeren van een pilotstudie of haalbaarheidsstudie [16]: in een pilotstudie kunnen 
kwesties als werving en selectie, uitval en therapietrouw van de deelnemers verkend 
worden. Tevens kunnen voorlopige gegevens over doeltreffendheid van de interventie 
worden verkregen. Tijdens deze pilotfase worden het behandelplan, het protocol, en 
eventuele trainingsschema’s ontwikkeld. 
- Individuele therapiesessies: de zorg voor kwetsbare patiënten met de ZvH vraagt om een 
individuele benadering om aan de complexe behoeftes van deze patiënten tegemoet 
te komen. Om de geplande interventie-componenten te kunnen aanbieden verdient 
individuele therapie de voorkeur boven groepstherapie gezien de onderling vaak grote 
verschillen in cognitieve staat van de patiënten. 
- Meetinstrumenten: de kracht van muziektherapie ligt in het feit dat de sessies op maat 
gesneden kunnen worden om daarmee de individueel opgezette doelen van elke pati-
ent te behalen [4,5]. Het gebruik van het hiervoor genoemde GAS meetinstrument [15] 
om deze doelen te bepalen is aan te bevelen. Een mogelijk ander goed alternatief voor 
toekomstig onderzoek is het gebruik (na validatie) van de eveneens hiervoor genoemde 
MATA-HD [12] en de UHDRS-FAP [14]. 
- Het ontwerpen van multipele n=1 studies; dit is een ontwerp dat vaak wordt gebruikt 
in bepaalde vakgebieden binnen de psychologie en gedragswetenschappen waarin het 
subject zijn eigen controle is in plaats van een ander individu. Dit soort onderzoek is uiterst 
flexibel en benadrukt de individuele verschillen in reacties op interventie-effecten op 
verschillende domeinen [18]. Met n=1 studies doorgrond je het veranderingsproces van 
patiënten met betrekking tot de complexiteit van muziektherapie [19]. 
- Het betrekken van mantelzorgers: in toekomstige studies is de overweging om familie-
leden en mantelzorgers in het onderzoek te betrekken de moeite waard, omdat dit de 
communicatie tussen hen en de patiënt ook buiten de muziektherapie-sessies ten goede 
komt. Dit is niet alleen een uiterst wenselijk resultaat dat ongetwijfeld leidt tot verbetering 
van de KvL voor zowel de patiënt maar ook de mantelzorger [5], maar ook zal de inbreng 
van zowel de patiënt als de mantelzorger een waardevolle bron zijn om toekomstige 
klinische studies richting te helpen geven [20]. 
De gunstige effecten van muziektherapie voor patiënten met de ZvH konden in het onderha-
vige onderzoek niet aangetoond worden middels het design en de gebruikte uitkomstmaten 
[8]. 
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Dit impliceert dat ofwel muziektherapie niet effectief is, of de gekozen uitkomstmaten (com-
municatieve en expressieve vaardigheden en probleemgedrag) zijn niet geschikt om de 
effectiviteit aan te tonen. Ondanks de complexiteit van zowel de onderzoekspopulatie alsook 
de interventie, is het haalbaar om een RCT uit te voeren. Om de effectiviteit van de inter-
ventie te kunnen aantonen moet de RCT worden voorafgegaan, vergezeld of aangevuld door 
andere observationele of kwalitatieve studies en moeten de meest geschikte en beschikbare 
uitkomstmaten en meetinstrumenten worden gebruikt.
Conclusie
Wanneer de effectiviteit van interventies die de potentie hebben om de KvL te verbeteren 
geëvalueerd moet worden, is het vinden van de meest geschikte onderzoeksopzet en uitkomst-
maten een hele uitdaging. Voor de muziektherapie-onderzoeker ligt deze uitdaging vooral in 
het vinden van alternatieve studieontwerpen en in het leren vanuit ervaringen van andere 
onderzoeken waar complexe interventies bij gemoeid waren. Dit vergt van het multidiscipli-
naire team rondom de patiënt met de ZvH de bereidwilligheid om te leren, samen te werken 
en om creatief te zijn [17].
In een poging om een bijdrage te leveren aan de evidentie van muziektherapie en uitgaande 
van de hiervoor genoemde aanname dat deze methodiek wordt beschouwd als de gouden 
standaard wanneer de effectiviteit van gezondheidszorg-interventies aangetoond moet 
worden, hebben we gekozen voor de RCT-methodiek in het onderhavige onderzoek. Geble-
ken is dat het uitvoeren van een multi-center RCT naar de effecten van muziektherapie bij 
kwetsbare patiënten die in een faciliteit voor langdurige zorg verblijven haalbaar maar zeer 
uitdagend is. 
Echter, in de alledaagse praktijk van de muziektherapeut worden de strikte regels die gelden 
voor de RCT, waar de te onderzoeken interventie gestandaardiseerd moet worden om de expe-
rimentele groep met de controlegroep te kunnen vergelijken, beschouwd als hindernissen die 
moeten worden genomen [9,21]. Deze strikte regels conflicteren met wat er in de definitie van 
muziektherapie staat geschreven, namelijk dat behandeldoelen moeten worden aangepast 
aan het functieniveau van de patiënt teneinde deze individuele doelen te kunnen behalen. De 
toegevoegde waarde van muziektherapie is dat de interventie kan worden aangepast aan de 
individuele behoeftes en mogelijkheden van de patiënt. De geïndividualiseerde wijze waarop 
muziektherapie ingrijpt op elk patiënt is wat de therapie effectief maakt. Het is daarom niet 
de inhoud die gestandaardiseerd zou moeten worden, maar de functie van de interventie. 
Zodoende staat het de therapeut vrij om elke denkbare techniek of methode volgens een 
gestandaardiseerd protocol te integreren teneinde specifieke doelen te bereiken [9,21]. 
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